Skip to main content
SNO 28th Annual Meeting Main banner
Final Program


Program
Icon Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
ISS CME
ISS CME
Named Award Winner
Named Award Winner
Award Winner
Award Winner
Poster Award Winner
Poster Award Winner

  1. Home

  • Friday, Nov 17th
    8:35 AM – 8:40 AM PT
    CTNI-22 - A phase 0/2 ‘trigger’ trial of niraparib in patients with newly-diagnosed glioblastoma
    Location: Room 121-122
    Oral Abstract Presenter: Nader Sanai – Barrow Neurological Institute
    Author: Tigran Margaryan – Ivy Brain Tumor Center
    Author: Jennifer Molloy – Ivy Brain Tumor Center
    Author: Hualin Zhang – Ivy Brain Tumor Center
    Author: William L. Knight – Ivy Brain Tumor Center/University of Arizona College of Medicine
    Author: Jocelyn Harmon – Ivy Brain Tumor Center
    Author: Amy Hong – Ivy Brain Tumor Center
    Author: John Wanebo – Barrow Neurological Institute
    Author: William Kennedy – Barrow Neurological Institute
    Author: Kelly Braun – Barrow Neurological Institute
    Author: Michael A. Garcia – GT Medical Technologies
    Author: Igor Barani – Saint Joseph's Hospital and Medical Center
    Author: Wonsuk Yoo – Barrow Neurological Institute
    Author: An-Chi Tien – Ivy Brain Tumor Center
    Author: Artak Tovmasyan – Barrow Neurological Institute
    Author: Shwetal Mehta – Ivy Brain Tumor Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    9:05 AM – 9:15 AM PT
    LTBK-09 - Results of BMX-HGG study: a multi-institutional, randomized phase 2 clinical trial of concurrent chemoradiation with or without BMX-001 in patients with newly diagnosed high grade glioma
    Location: Exhibit Hall C
    Late Breaking Abstract Presenter: Katherine B. Peters – Duke University Medical Center
    Author: Adam L. Cohen – Inova
    Author: Nicholas A. Butowski – University of California San Francisco
    Author: John L. Villano – University of Kentucky
    Author: Joe Mendez – Huntsman Cancer Institute at the University of Utah
    Author: Pierre Giglio – The Ohio State University Wexner Medical Center
    Author: Tresa McGranahan – Scripps Cancer Center
    Author: Chi Zhang – University of Nebraska Medical Center
    Author: Jacob P. Smeltzer – Saint Luke's Cancer Institute
    Author: Shahzad Raza – Cleveland Clinic
    Author: Burt Nabors – Heersink School of Medicine
    Author: Mina Lobbous – Cleveland Clinic Case Western Reserve University
    Author: James E. Herndon, II – Duke Cancer Institute, Department of Biostatistics
    Author: Evan D. Buckley – Duke Cancer Institute, Department of Biostatistics
    Author: David MacLeod – BioMimetix
    Author: Sara Penchev – BioMimetix
    Author: David S. Silberstein – BioMimetix
    Author: Ines Batinic-Haberle – Duke University Medical Cener
    Author: Ivan Spasojevic – Duke University Medical Center
    Author: Shayne C. Gad – Gad Consulting Services
    Author: David Radoff – Duke University Medical Center
    Author: Daniel P. Barboriak – Duke University Medical Center
    Author: James Crapo – BioMimetix
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    10:15 AM – 10:25 AM PT
    CTNI-24 - Clinical activity and safety of the RAF inhibitor tovorafenib in patients with optic pathway gliomas in the registrational pediatric low-grade glioma arm of the phase 2 FIREFLY-1 (PNOC026) study
    Location: Exhibit Hall C
    Plenary Abstract Presenter: Karsten Nysom – Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet
    Author: Lindsay B. Kilburn – Children’s National Hospital
    Author: Sarah E. S. Leary – Cancer and Blood Disorders Center, Seattle Children's
    Author: Daniel B. Landi – Duke University
    Author: E. de Vos-Kerkhof – Princess Máxima Center for Pediatric Oncology
    Author: Sébastien Perreault – CHU Sainte Justine
    Author: Olaf Witt – Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
    Author: David S. Ziegler – Kids Cancer Centre, Sydney Children’s Hospital
    Author: Pablo Hernáiz Driever – German HIT-LOGGIC-Registry for LGG in children and adolescents, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin
    Author: Andrea T. Franson – University of Michigan
    Author: Patricia A. Baxter – Texas Children's Cancer Center, Texas Children's Hospital
    Author: Nicholas S. Whipple – Primary Children’s Hospital, University of Utah
    Author: Cassie Kline – Children's Hospital of Philadelphia
    Author: Devorah Segal – NYU Langone Health
    Author: Nada Jabado – Research Institute McGill University Health Centre (MUHC) - The Montreal Children's Hospital (MCH)
    Author: Simon Bailey – Great North Childrens Hospital and Newcastle University
    Author: Geoffrey McCowage – Sydney Children’s Hospitals Network
    Author: Jordan R. Hansford – Children's Cancer Centre, Royal Children’s Hospital Melbourne
    Author: Dong-Anh Khuong-Quang – The Royal Children's Hospital Melbourne
    Author: Nicholas G. Gottardo – Perth Children's Hospital
    Author: Timothy Hassall – Children’s Health Queensland Hospital and Health Service
    Author: Jung Woo Han – Severance Hospital, Yonsei University Health System
    Author: Michal Yalon Oren – Sheba Medical Center
    Author: Susan N. Chi – Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA
    Author: Vai Lee – Day One Biopharmaceuticals
    Author: Lisa McLeod – Day One Biopharmaceuticals
    Author: Jiaheng Qiu – Day One Biopharmaceuticals
    Author: Ashley Walter – Day One Biopharmaceuticals
    Author: Peter Manley – Day One Biopharmaceuticals
    Author: Darren Hargrave – UCL Great Ormond Street Institute of Child Health
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    10:25 AM – 10:35 AM PT
    CTNI-37 - Clinical activity of RAF inhibitor tovorafenib according to prior MAPK inhibitor treatment in the registrational pediatric low-grade glioma arm of the phase 2 FIREFLY-1 (PNOC026) study
    Location: Exhibit Hall C
    Author: Dong-Anh Khuong-Quang – The Royal Children's Hospital Melbourne
    Author: Karsten Nysom – Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet
    Plenary Abstract Presenter: Daniel B. Landi – Duke University
    Author: David S. Ziegler – Kids Cancer Centre, Sydney Children’s Hospital
    Author: Pablo Hernáiz Driever – German HIT-LOGGIC-Registry for LGG in children and adolescents, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin
    Author: Sarah E. S. Leary – Cancer and Blood Disorders Center, Seattle Children's
    Author: Simon Bailey – Great North Childrens Hospital and Newcastle University
    Author: Jasper van der Lugt – Princess Máxima Center for Pediatric Oncology
    Author: Sébastien Perreault – CHU Sainte Justine
    Author: Angela J. Waanders – Ann & Robert H Lurie Children's Hospital
    Author: Patricia A. Baxter – Texas Children's Cancer Center, Texas Children's Hospital
    Author: Olaf Witt – Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
    Author: Darren Hargrave – UCL Great Ormond Street Institute of Child Health
    Author: Geoffrey McCowage – Sydney Children’s Hospitals Network
    Author: Jordan R. Hansford – Children's Cancer Centre, Royal Children’s Hospital Melbourne
    Author: Helen Toledano – Schneider Children’s Medical Center of Israel
    Author: Liat Oren – Rambam Healthcare Campus
    Author: Enrica E. K. Tan – KK Women's and Children's Hospital
    Author: Nicolas Gerber – University Children's Hospital
    Author: Hyoung Jin Kang – Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children’s Hospital
    Author: Valérie Larouche – CHU de Québec-Université Laval (CHUL)
    Author: Mohamed S. S. Abdelbaki – St. Louis Children's Hospital (NCH)
    Author: Izzy Cornelio – Day One Biopharmaceuticals
    Author: Yeonhee Kim – Day One Biopharmaceuticals
    Author: Ashley Walter – Day One Biopharmaceuticals
    Author: Peter Manley – Day One Biopharmaceuticals
    Author: Lindsay B. Kilburn – Children’s National Hospital
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    3:45 PM – 3:55 PM PT
    CTNI-75 - Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors: an updated analysis
    Location: Room 109-110
    Oral Abstract Presenter: Sébastien Perreault – CHU Sainte Justine
    Author: François Doz – SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie
    Author: Birgit Geoerger – Gustave Roussy Cancer Center, Department of Paediatric and Adolescent Oncology, INSERM 1015, Université Paris-Saclay
    Author: Antoine Italiano – Early Phase Trials Unit, Institut Bergonie
    Author: Ulrik N. Lassen – Department of Oncology, Rigshospitalet, University Hospital Copenhagen
    Author: Anna Nilsson – Department of Paediatric Oncology, Karolinska University Hospital
    Author: Karsten Nysom – Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet
    Author: Jean-Philippine Spano – Pitié-Salpétrière Hospital
    Author: Ricarda Norenberg – Chrestos Concept GmbH & Co. KG
    Author: Vadim Bernard-Gauthier – Bayer HealthCare Pharmaceuticals, Inc.
    Author: Esther de la Cuesta – Bayer HealthCare Pharmaceuticals, Inc.
    Author: Alexander Drilon – Memorial Sloan Kettering Cancer Center
    Author: Theodore Laetsch – Children's Hospital of Philadelphia
    Author: Cornelis M. van Tilburg – Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ)
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    3:55 PM – 4:05 PM PT
    CTNI-76 - Efficacy of BRAF inhibitor plixorafenib (FORE8394) in recurrent, primary central nervous system tumors (PCNST)
    Location: Room 109-110
    Oral Abstract Presenter: Macarena I. de la Fuente – Sylvester Comprehensive Cancer Center
    Author: Nicholas A. Butowski – University of California San Francisco
    Author: Jennie W. Taylor – University of California San Francisco
    Author: Rona Yaeger – Memorial Sloan Kettering Cancer Center
    Author: Frank Yung-Chin Tsai – Honor Health Research Institute
    Author: Filip Janku – MD Anderson Cancer Center
    Author: Carl Allen – Baylor College of Medicine, Texas Children's Hospital
    Author: Natraj Ammakkanavar – Community Health Network, Cancer Center
    Author: Glenn Michelson – Fore Biotherapeutics
    Author: Ping Jiang – Fore Biotherpeutics
    Author: Michael Paz – Fore Biotherapeutics
    Author: Alexia Tussay-Lindenberg – Fore Biotherapeutics
    Author: Kongming Wang – Fore Biotherapeutics
    Author: Stacie Peacock Shepherd – Fore Biotherapeutics
    Author: Irina Kline – Fore Biotherapeutics
    Author: Eric Sherman – Memorial Sloan Kettering Cancer Center
    Author: Jordi Rodon – Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    4:05 PM – 4:15 PM PT
    CTNI-25 - A phase 0/1b study of AZD1390 plus radiotherapy in recurrent glioblastoma patients
    Location: Room 109-110
    Oral Abstract Presenter: Nader Sanai – Barrow Neurological Institute
    Author: Siddhi Desai – Ivy Brain Tumor Center
    Author: Tigran Margaryan – Ivy Brain Tumor Center
    Author: Costanza LoCascio – Ivy Brain Tumor Center
    Author: Mackenna Elliott – Ivy Brain Tumor Center
    Author: Jennifer Molloy – Ivy Brain Tumor Center
    Author: Jocelyn Harmon – Ivy Brain Tumor Center
    Author: Amy Hong – Ivy Brain Tumor Center
    Author: Ernesto Luna Melendez – Ivy Brain Tumor Center
    Author: John Wanebo – Barrow Neurological Institute
    Author: Kelly Braun – Barrow Neurological Institute
    Author: William Kennedy – Barrow Neurological Institute
    Author: Michael A. Garcia – GT Medical Technologies
    Author: Wonsuk Yoo – Barrow Neurological Institute
    Author: Artak Tovmasyan – Barrow Neurological Institute
    Author: An-Chi Tien – Ivy Brain Tumor Center
    Author: Shwetal Mehta – Ivy Brain Tumor Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    4:15 PM – 4:25 PM PT
    CTNI-61 - Mycophenolate mofetil inhibits glioblastoma purine metabolism in humans: an interim result of phase 0/1 clinical trial to overcome treatment resistance in newly diagnosed and recurrent glioblastoma
    Location: Room 109-110
    Oral Abstract Presenter: Yoshie Umemura – Ivy Brain Tumor Center at Barrow Neurological Institute
    Author: Wajd Al-Holou – University of Michigan
    Author: Ameer Elaimy – University of Michigan
    Author: Andrew J. Scott – University of Michigan
    Author: Denise Leung – University of Michigan
    Author: Nathan Clarke – University of Michigan
    Author: Michelle M. M. Kim – Department of Radiation Oncology, University of Michigan Hospital
    Author: Sean P. Ferris – University of Michigan
    Author: Jennifer Thomas – University of Michigan
    Author: Jason Heth – University of Michigan
    Author: Matthew Schipper – University of Michigan
    Author: Krithika Suresh – University of Michigan
    Author: Theodore S. Lawrence – University of Michigan
    Author: Daniel R. Wahl – University of Michigan
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    4:25 PM – 4:35 PM PT
    CTNI-64 - Efficacy and Safety of Erdafitinib in Patients With High-grade and Low-grade Gliomas and Prespecified Fibroblast Growth Factor Receptor Alterations (FGFRalt) in the RAGNAR Trial
    Location: Room 109-110
    Oral Abstract Presenter: David A. Reardon – Center for Neuro-Oncology, Dana-Farber Cancer Institute
    Author: Liam Welsh – The Royal Marsden NHS Foundation Trust
    Author: Kent Shih – Sarah Cannon Research Institute and Tennessee Oncology
    Author: Toshio Shimizu – Wakayama Medical University Hospital, National Cancer Center Hospital
    Author: Jean-Charles Goeminne – CHU-UCL-Namur, site Sainte-Elisabeth
    Author: Birgit Geoerger – Gustave Roussy Cancer Center, Department of Paediatric and Adolescent Oncology, INSERM 1015, Université Paris-Saclay
    Author: Capucine Baldini – Drug Development Department (DITEP), Gustave Roussy
    Author: Christophe Massard – Université Paris-Saclay, Le Kremlin Bicêtre – France INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, Paris, France
    Author: Yohann Loriot – Gustave Roussy, Université Paris-Saclay
    Author: Shubham Pant – The University of Texas MD Anderson Cancer Center
    Author: Sameer Farouk F. Sait – Memorial Sloan Kettering Cancer Center
    Author: Shibu Thomas – Janssen Research & Development
    Author: Constance Hammond – Janssen Research & Development
    Author: Saltant Najmi – Janssen Research & Development
    Author: Spyros Triantos – Janssen Research & Development
    Author: Lauren Crow – Janssen Research & Development
    Author: Hussein Sweiti – Janssen Research & Development
    Author: Olaf Witt – Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    4:35 PM – 4:45 PM PT
    CTNI-41 - Phase II and Phase 0 results of ABTC 1801: a multi-arm clinical trial of the PARP inhibitor pamiparib with very low dose metronomic temozolomide in recurrent IDH mutant gliomas
    Location: Room 109-110
    Oral Abstract Presenter: David Schiff – University of Virginia School of Medicine
    Author: Ranjit S. S. Bindra – Department of Therapeutic Radiology, Yale School of Medicine
    Author: Jing Li – Karmanos Cancer Institute, Wayne State University
    Author: Xiaobu Ye – Johns Hopkins university
    Author: Benjamin M. Ellingson – UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, University of California Los Angeles
    Author: Tobias Walbert – Henry Ford Health
    Author: Jian L. Campian – Mayo Clinic
    Author: Burt Nabors – Heersink School of Medicine
    Author: Frank S. Lieberman – University of Pittsburg
    Author: Byram Ozer – National Cancer Insitute, National Institutes of Health
    Author: Arati S. Desai – University of Pennsylvania
    Author: Antonio Omuro – Yale University
    Author: Patrick Y. Wen – Dana-Farber Cancer Institute
    Author: Serena Desideri – Johns Hopkins
    Author: Neeraja Danda – Johns Hopkins
    Author: Stuart A. Grossman – Department of Oncology, Johns Hopkins University School of Medicine
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    4:45 PM – 4:50 PM PT
    CTNI-58 - Updated results and molecular subgroup analyses from the randomized phase 3 MIRAGE trial on marizomib in patients with newly diagnosed glioblastoma
    Location: Room 109-110
    Oral Abstract Presenter: Patrick Roth – Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland
    Author: Thierry Gorlia – EORTC headquarter
    Author: Jaap Reijneveld – Dept. of Neurology, Amsterdam University Medical Centers
    Author: Filip Y. de Vos – University Medical Center
    Author: Ahmed Idbaih – Sorbonne Université, AP-HP, ICM, Hôpital Universitaire La Pitié-Salpêtrière
    Author: Jean-Sébastien Frenel – Institut de cancérologie de l'Ouest
    Author: Emilie Le Rhun – Departments of Neurosurgery and Neurology, University Hospital and University of Zurich
    Author: Juan M. Sepúlveda – Hospital Universitario 12 de Octubre
    Author: James Perry – Sunnybrook Health Sciences Centre, University of Toronto
    Author: G. Laura Masucci – CHU Montreal
    Author: Pierre Freres – Department of Medical Oncology, University Hospital of Liège, CHU Sart Tilman
    Author: Hal Hirte – McMaster University
    Author: Clemens Seidel – Department of Radiotherapy and Radiation Oncology, University Hospital Leipzig, Leipzig, Germany
    Author: Annemiek Walenkamp – University of Groningen
    Author: Slavka Lukacova – Aarhus University
    Author: Paul Meijnders – University of Antwerp
    Author: Andre Blais – CHU de Québec
    Author: Francois Ducray – Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon
    Author: Vincent Verschaeve – Grand Hôpital De Charleroi
    Author: Garth Nicholas – University of Ottawa
    Author: Carmen Balana – Institut Català d'Oncologia
    Author: Daniela A. Bota, MD, PhD – University of California Irvine
    Author: Matthias Preusser – Medical University of Vienna
    Author: Sarah Nuyens – EORTC
    Author: Fréderic Dhermain – Institut Gustave Roussy
    Author: Martin J. van den Bent – Erasmus MC Cancer Institute
    Author: Chris J. O’Callaghan – Queen's Cancer Research Institute
    Author: Maureen Vanlancker – EORTC
    Author: Warren P. Mason – Princess Margaret Cancer Centre
    Author: Michael Weller – Department of Neurology and Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    4:50 PM – 4:55 PM PT
    CTNI-54 - A combined analysis of two randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
    Location: Room 109-110
    Oral Abstract Presenter: Lucy Gately – Walter and Eliza Hall Institute of Medical Research
    Author: Carlos Mesia – Institut Català d'Oncologia, Hospitalet de Llobregat
    Author: Juan M. Sepúlveda – Hospital Universitario 12 de Octubre
    Author: Sonia del Barco – Institut Català d'Oncologia Girona
    Author: Estela Pineda – Hospital Clinic de Barcelona
    Author: Regina Gironés – Hospital Universitario La Fe
    Author: José Fuster – Hospital Son Espases
    Author: Wei Hong – Walter and Eliza Hall Institute of Medical Research
    Author: Sanjeev Gill – Alfred Hospital
    Author: Luis Miguel Navarro – Hospital de Salamanca
    Author: Ana Herrero – Hospital Miguel Servet
    Author: Anthony Dowling – St Vincent's Hospital Melbourne
    Author: Ramón De La Peñas – Hospital Provincial de Castellón
    Author: Maria Angeles Vaz – Hospital Ramón y Cajal
    Author: Miriam Alonso – Hospital Virgen del Rocio
    Author: Zarnie Lwin – Royal Brisbane and Women’s Hospital
    Author: Rosemary A. Harrup – Royal Hobart Hospital
    Author: Sergio Peralta – Hospital Sant Joan de Reus
    Author: Anne Long – Sir Charles Gairdner Hospital
    Author: Pedro Perez-Segura – Hospital Clinico San Carlos
    Author: Elizabeth Ahern – Monash Health
    Author: Clara Olier Garate – Hospital Universitario Fundación Alcorocón
    Author: Mark Wong – Westmead Hospital
    Author: Robert Campbell – Bendigo Health
    Author: Katharine Cuff – Princess Alexandra Hospital
    Author: Ross Jennens – Epworth Health
    Author: Oscar Gallego – Hospital de la Santa Creu I Sant Pau
    Author: Craig Underhill – Border Medical Oncology Research Unit
    Author: María Martinez-García – Hospital del Mar
    Author: Marta Covela – Hospital Lucus Augusti
    Author: Adam Cooper – Liverpool Hospital
    Author: Stephen Brown – Ballarat Health Services
    Author: Mark A. Rosenthal – Peter MacCallum Cancer Centre
    Author: Javier Torres – Goulburn Valley Heatlh
    Author: Ian M Collins – South West Regional Cancer Centre
    Author: Peter Gibbs – Walter and Eliza Hall Institute for Medical Research
    Author: Carmen Balana – Institut Català d'Oncologia
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    4:55 PM – 5:00 PM PT
    CTNI-23 - Single cell transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0 trial of recurrent high-grade glioma
    Location: Room 109-110
    Oral Abstract Presenter: Kevin Johnson – Yale University School of Medicine
    Author: An-Chi Tien – Ivy Brain Tumor Center
    Author: Jun Jiang – Karmanos Cancer Institute
    Author: James McNamara – Ivy Brain Tumor Center
    Author: Yu-Wei Chang – Ivy Brain Tumor Center
    Author: Chelsea Montgomery – Ivy Brain Tumor Center
    Author: Anita DeSantis – Ivy Brain Tumor Center
    Author: Leonel Elena – Ivy Brain Tumor Center
    Author: Yoko Fujita – Ivy Brain Tumor Center
    Author: Seongho Kim – Karmanos Cancer Institute
    Author: Artak Tovmasyan – Barrow Neurological Institute
    Author: Jing Li – Karmanos Cancer Institute, Wayne State University
    Author: Shwetal Mehta – Ivy Brain Tumor Center
    Author: Roel Verhaak – Yale University School of Medicine
    Author: Nader Sanai – Barrow Neurological Institute
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    5:00 PM – 5:05 PM PT
    CTNI-67 - First in human study of DSP-0390, an oral emopamil binding protein (EBP) inhibitor, in recurrent high-grade glioma (HGG): preliminary results
    Location: Room 109-110
    Oral Abstract Presenter: Yoshiki Arakawa – Department of Neurosurgery, Kyoto University Graduate School of Medicine
    Author: Samuel A. Goldlust – Saint Luke’s Marion Bloch Neuroscience Institute
    Author: Howard Colman – Huntsman Cancer Institute, University of Utah
    Author: David A. Reardon – Center for Neuro-Oncology, Dana-Farber Cancer Institute
    Author: Mary R. Welch – Columbia University Irving Medical Center
    Author: Shigeru Yamaguchi – Hokkaido University Graduate School of Medicine
    Author: Nicholas A. Butowski – University of California San Francisco
    Author: Jian Li – Sumitomo Pharma Oncology
    Author: Shuichi Iino – Sumitomo Pharma Oncology
    Author: Gregory Song, PhD – Sumitomo Pharma Oncology
    Author: Aimee Jackman – Sumitomo Pharma Oncology
    Author: Yuran Xie – Sumitomo Pharma Oncology
    Author: Marie-Claire Wagle – Sumitomo Pharma Oncology
    Author: Claudia Lebedinsky – Sumitomo Pharma Oncology
    Author: YOSHITAKA NARITA – National Cancer Center Hospital
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    5:05 PM – 5:10 PM PT
    CTNI-21 - Phase I study of BTK inhibitor ibrutinib with temozolomide and radiation in newly-diagnosed glioblastoma (EQUILIBRIUM): final trial report
    Location: Room 109-110
    Oral Abstract Presenter: Manmeet S. Ahluwalia – Miami Cancer Institute, Baptist Health South Florida
    Author: Ahmad Ozair – Miami Cancer Institute, Baptist Health South Florida
    Author: Atulya Khosla – Miami Cancer Institute, Baptist Health South Florida
    Author: Neha Patel – Cleveland Clinic, Ohio
    Author: Paul Elson – Cleveland Clinic, Ohio
    Author: Erin S. Murphy – Cleveland Clinic
    Author: Samuel T. Chao – Cleveland Clinic, Ohio
    Author: John H. Suh – Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic
    Author: Glen H. Stevens – Cleveland Clinic
    Author: David M. Peereboom – Cleveland Clinic, Ohio
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:58 PM – 8:02 PM PT
    CTNI-52 - Survival Outcomes in Recurrent Glioblastoma (rGBM) Patients Treated with a Single Intra-tumoral Administration of Bizaxofusp, an IL-4R-targeting Toxin, in a Phase IIb Trial
    Location: Exhibit Hall A/B
    Author: John H. Sampson – Duke University
    Author: Achal Singh Achrol – Loma Linda University Medical Center
    Author: Manish K. Aghi – University of California, San Francisco
    Author: Krystof Bankiewicz – Ohio State University College of Medicine
    Author: Martin Bexon – Medicenna Therapeutics
    Rapid and Poster Presenter: Steven Brem – University of Pennsylvania
    Author: Andrew J. Brenner – UT Health San Antonio Mays Cancer Center
    Author: Sajeel Chowdhary – Boca Raton Regional Hospital
    Author: Melissa Coello – Medicenna Therapeutics
    Author: Annick Desjardins – Duke University
    Author: Benjamin M. Ellingson – UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, University of California Los Angeles
    Author: John Floyd – UT Health Science Center San Antonio
    Author: Seunggu Han – Stanford University
    Author: Santosh Kesari – Pacific Neuroscience Institute
    Author: Yael Mardor – The Advanced Technology Center, Sheba Medical Center
    Author: Fahar Merchant – Medicenna Therapeutics
    Author: Rosemina Merchant – Medicenna Therapeutics
    Author: Dina Randazzo – Duke University Medical Center
    Author: Michael A. A. Vogelbaum – Department of NeuroOncology, Moffitt Cancer Center
    Author: Frank Vrionis – Boca Raton Regional Hospital
    Author: Eva Wembacher-Schroeder – Brainlab AG
    Author: Minh D. To – Medicenna Therapeutics
    Author: Miroslaw Zabek – Mazovian Bronowski Hospital
    Author: Nicholas A. Butowski – University of California San Francisco
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    8:10 PM – 8:14 PM PT
    CTNI-15 - Pilot study of high-dose pemetrexed for progressive chordoma
    Location: Exhibit Hall A/B
    Rapid and Poster Presenter: Santosh Kesari – Pacific Neuroscience Institute
    Author: Naveed Wagle – Pacific Neuroscience Institute
    Author: Jose A. Carrillo – Pacific Neuroscience Institute
    Author: Akanksha Sharma – Pacific Neuroscience Institute/Saint John's Cancer Institute
    Author: Minhdan Nguyen, PA-C – Pacific Neuroscience Institute
    Author: Judy D. Truong, PA-C – Pacific Neuroscience Institute
    Author: Jaya Gill, MD, MHA – Pacific Neuroscience Institute
    Author: Raffi Nersesian – Saint John’s Cancer Institute at Providence Saint John’s Health Center
    Author: Natsuko Nomura – Pacific Neuroscience Institute
    Author: Elnaz Rahbarlayegh – Pacific Neuroscience Institute
    Author: Garni Barkhoudarian – Pacific Neuroscience Institute
    Author: Walavan Sivakumar – Pacific Neuroscience Institute
    Author: Daniel F. Kelly – Pacific Neuroscience Institute
    Author: Howard Krauss – Pacific Neuroscience Institute
    Author: Matias Bustos – Saint John’s Cancer Institute at Providence Saint John’s Health Center
    Author: Dave SB Hoon – Saint John’s Cancer Institute at Providence Saint John’s Health Center
    Author: Lars Anker – Providence St. Joseph Hospital Orange
    Author: Arun S. Singh – UCLA Health, Santa Monica Cancer Care
    Author: Kamalesh Sankhala – Cedars-Sinai, Samuel Oschin Cancer Center
    Author: Tiffany M. Juarez – Saint John’s Cancer Institute at Providence Saint John’s Health Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    8:14 PM – 8:18 PM PT
    CTNI-26 - Efficacy and Safety of Metformin plus Low-Dose Temozolomide in Patients with Recurrent or Refractory Glioblastoma: A Randomized, Prospective, Multicenter, Double-Blind, Controlled, Phase 2 Trial
    Location: Exhibit Hall A/B
    Author: Wan Soo Yoon – Department of Neurosurgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea
    Author: Jong Hee Chang – Severance Hospital, Yonsei University College of Medicine
    Author: Jeong Hoon Kim – Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    Author: Yu Jung Kim – Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
    Author: Tae Young Jung – Department of Neurosurgery, Chonnam National University Hwasun Hospital, Hwasun, Korea.
    Author: Heon Yoo – Department of Neuro-Oncology Clinic, Center for Specific Organs Cancer, National Cancer Center Hospital, National Cancer Center, Goyang, Korea.
    Author: Se-Hyuk Kim – Department of Neurosurgery, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea.
    Author: Do-Hyun Nam – Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Author: Tae Min Kim – Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
    Author: Se Hoon Kim – Yonsei University College of Medicine
    Author: Sung Hye Park – Department of Pathology, Seoul National University Hospital, Seoul, Korea.
    Author: Youn Soo Lee – Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Author: Hyeon Woo kim – Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Author: Yong-Kil Hong – Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Rapid and Poster Presenter: Seung Ho Yang – Department of Neurosurgery, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-01 - Long-term results from a phase 1 trial of spine SBRT in inoperable patients with cord compression
    Location: Exhibit Hall A/B
    Poster Presenter: Amol J. Ghia – University of Texas, MD Anderson Cancer Center
    Author: Nandita Guha-Thakurta – University of Texas, MD Anderson Cancer Center
    Author: Jing Li – University of Texas, MD Anderson Cancer Center
    Author: Mary Frances McAleer – University of Texas, MD Anderson Cancer Center
    Author: Tina M. Briere – University of Texas, MD Anderson Cancer Center
    Author: Claudio E. Tatsui – Department of Neurosurgery, MD Anderson Cancer Center
    Author: Paul D. Brown – Mayo Clinic
    Author: Thomas Beckham – University of Texas, MD Anderson Cancer Center
    Author: Chenyang Wang – University of Texas, MD Anderson Cancer Center
    Author: D. Nana Yeboa – The University of Texas MD Anderson Cancer Center
    Author: Eric Chang – USC Keck School of Medicine
    Author: Laurence Rhines – University of Texas, MD Anderson Cancer Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-02 - A Longitudinal Therapy Response Monitoring Study in Subjects with Leptomeningeal Metastases using CNSide Compared to Standard of Care (CSF Cytology, Clinical Evaluation, Imaging)
    Location: Exhibit Hall A/B
    Poster Presenter: Seema Nagpal – Division of Neuro-oncology, Stanford University
    Author: Michael Youssef – UT Southwestern Medical Center
    Author: Sue Beruti – Biocept, Inc.
    Author: Laura Gillis – Biocept, Inc.
    Author: Kelly Gordon – BoudiccaDx
    Author: Barbara Blouw, California – Biocept, Inc.
    Author: Priya U. Kumthekar – Northwestern University
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-06 - Rhenium (Re-186) obisbemeda{Re-186-Nanoliposome (186RNL)} in Leptomeningeal Metastases [LM] Phase 1/2a Dose Escalation Trial: Initial Safety and Feasibility
    Location: Exhibit Hall A/B
    Poster Presenter: Andrew J. Brenner – UT Health San Antonio Mays Cancer Center
    Author: Michael Youssef – UT Southwestern Medical Center
    Author: Priya U. Kumthekar – Northwestern University
    Author: Joel Michalek – UT Health San Antonio Mays Cancer Center
    Author: Marc Hedrick – PLUS Therapeutics
    Author: Ande Bao – Case Western Reserve University
    Author: William T. Phillips – UT Health San Antonio Mays Cancer Center
    Author: Toral R. Patel – UT Southwestern Medical Center
    Author: Jeffrey S. Weinberg – MD Anderson Cancer Center
    Author: John Floyd – UT Health Science Center San Antonio
    Author: Norman LaFrance – PLUS Therapeutics
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-07 - Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response
    Location: Exhibit Hall A/B
    Poster Presenter: Brandon S. Imber – Memorial Sloan Kettering Cancer Center
    Author: Vignesh Ravichandran – Memorial Sloan Kettering Cancer Center
    Author: Pavitra Rao – Memorial Sloan Kettering Cancer Center
    Author: Hilary Casanova – Memorial Sloan Kettering Cancer Center
    Author: John Friend – Kazia Therapeutics
    Author: Jeremy Simpson – Kazia Therapeutics
    Author: Luke Pike – Memorial Sloan Kettering Cancer Center
    Author: Melissa Zinovoy – Memorial Sloan Kettering Cancer Center
    Author: Ryan Mitchell – Memorial Sloan Kettering Cancer Center
    Author: Christina Chacko – Memorial Sloan Kettering Cancer Center
    Author: Rupesh Kotecha – Miami Cancer Institute, Baptist Health South Florida
    Author: Somica Somai – Memorial Sloan Kettering Cancer Center
    Author: Adrienne Boire – Memorial Sloan Kettering Cancer Center
    Author: Igor Gavrilovic – Memorial Sloan Kettering Cancer Center
    Author: Anna F. Piotrowski – Memorial Sloan Kettering Cancer Center
    Author: Jessica A. Wilcox – Memorial Sloan Kettering Cancer Center
    Author: Rachna Malani – University of Utah/Huntsman Cancer Institute
    Author: Robert J. Young – Memorial Sloan Kettering Cancer Center
    Author: Michael Offin – Memorial Sloan Kettering Cancer Center
    Author: Eli Diamond – Memorial Sloan Kettering Cancer Center
    Author: Jonathan T. Yang – University of Washington
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-08 - Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): a multicenter phase 1 clinical trial
    Location: Exhibit Hall A/B
    Poster Presenter: Manmeet S. Ahluwalia – Miami Cancer Institute, Baptist Health South Florida
    Author: Ahmad Ozair – Miami Cancer Institute, Baptist Health South Florida
    Author: Atulya Khosla – Miami Cancer Institute, Baptist Health South Florida
    Author: Shreyas Bellur – Miami Cancer Institute, Baptist Health South Florida
    Author: Rupesh Kotecha – Miami Cancer Institute, Baptist Health South Florida
    Author: Michael W. McDermott – Miami Neuroscience Institute
    Author: Minesh P. Mehta – Miami Cancer Institute
    Author: Ana Sandoval-Leon – Miami Cancer Institute, Baptist Health South Florida
    Author: Reshma Mahtani – Miami Cancer Institute, Baptist Health South Florida
    Author: David M. Peereboom – Cleveland Clinic, Ohio
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-10 - Sacituzumab govitecan for breast cancer brain metastasis
    Location: Exhibit Hall A/B
    Poster Presenter: Henriette U. Balinda – UT Health San Antonio
    Author: William Kelly – Mays Cancer Center
    Author: Pegah Ghamasaee – UT health science center San Antonio
    Author: Andrea Gilbert – University of Texas Health Science Center at San Antonio & University Hospital
    Author: Joel Michalek – UT Health San Antonio Mays Cancer Center
    Author: Virginia Kaklamani – Mays Cancer Center
    Author: Kate Lathrop – Mays Cancer Center
    Author: Prathibha Surapaneni – Mays Cancer Center
    Author: John Floyd – UT Health Science Center San Antonio
    Author: Andrew J. Brenner – UT Health San Antonio Mays Cancer Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-11 - The value of stereotactic biopsy of primary and recurrent brain metastases in the era ofprecision medicine
    Location: Exhibit Hall A/B
    Poster Presenter: Sophie Katzendobler – Department of Neurosurgery, University Hospital, LMU Munich
    Author: Anna Do – Department of Neurosurgery, Munich University Hospital, LMU Munich
    Author: Jonathan Weller – Department of Neurosurgery, University Hospital, LMU Munich
    Author: Kai Rejeski – Dept. of Medicine III - Hematology/Oncology, Ludwig Maximilians University (LMU), and German Cancer Consortium (DKTK) Partner Site,
    Author: Mario Dorostkar – Center for Neuropathology and Prion Research, LMU University Hospital, Ludwig Maximilians University (LMU), 81377 Munich, Germany
    Author: Nathalie L. Albert – Department of Nuclear Medicine, Ludwig Maximilians-University of Munich
    Author: Robert Forbrig – Institute of Neuroradiology, Munich University Hospital, LMU Munich, Munich, Germany
    Author: Maximilian Niyazi – Department of Radiation Oncology, Munich University Hospital, LMU Munich, Munich, Germany
    Author: Rupert Egensperger – 4Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität (LMU) Munich
    Author: Joerg-Christian Tonn – Department of Neurosurgery, University Hospital, LMU Munich
    Author: Louisa von Baumgarten – Dept. of Neurosurgery, Ludwig Maximilians University (LMU) Munich,
    Author: Stefanie Quach – Dept. of Neurosurgery, Ludwig Maximilians University (LMU) Munich,
    Author: Niklas Thon – Department of Neurosurgery, University Hospital, LMU Munich
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-12 - Genomic Analysis of Human Brain Metastases Treated with Stereotactic Radiosurgery Under the Phase-II Clinical Trial (NCT03398694) Reveals DNA Damage Repair at the Peripheral Tumor Edge.
    Location: Exhibit Hall A/B
    Poster Presenter: Jack M. Shireman – UW-Madison
    Author: Quinn White – UW-Madison
    Author: Namita Agrawal – IU
    Author: Zijan Ni – UW-Madison
    Author: Grace Chen – UW-Madison
    Author: Chitrasen Mohanty – UW-Madison
    Author: Lei Zhao – UW_Madison
    Author: Xiaohu Wang – UW-Madison
    Author: Atique U. Ahmed – Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University
    Author: James Miller – IU
    Author: Charles Kulwin – IU
    Author: Aaron Cohen-Gadol – Indiana University
    Author: Troy Payner – IU
    Author: Chih-Ta Lin – IU
    Author: Jesse Savage – IU
    Author: Brandon Lane – IU
    Author: Kevin Shiue – IU
    Author: Aaron Kamer – IU
    Author: Mitesh V. Shah – Indiana University Neuroscience Center
    Author: Gopal Iyer – UW-Madison
    Author: Gordon Watson – IU
    Author: Yong Zang – IU
    Author: LaKesha Boyd – IU
    Author: Tim Lautenschlaeger – IU
    Author: Christian Kendziorski – UW-Madison
    Author: Mahua Dey – UW-Madison
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-14 - Neoadjuvant Stereotactic Radiosurgery (NASRS) for Large Brain Metastases (BrM):  Results of an International Multicenter Phase II trial
    Location: Exhibit Hall A/B
    Poster Presenter: David B. Shultz – University of Toronto, Princess Margaret Cancer Centre
    Author: Dianna Li – St George Public and Private hospitals
    Author: Ruth Lau Rodriguez – Toronto Western Hospital
    Author: Randa Higazy – Princess Margaret Cancer Centre
    Author: Normand Laperriere – University Health Network-Princess Margaret Hospital
    Author: Barbara-Ann Millar – Princess Margaret Cancer Centre
    Author: Tatiana Conrad – Princess Margaret Cancer Centre
    Author: Gelareh Zadeh – University Health Network, Toronto Western Hospital
    Author: Aristotelis Kalyvas – Toronto Western Hospital
    Author: Carolin Senger – Charite
    Author: Gueliz Acker – Charite
    Author: Julian Spears – St. Michael's Hospital, University of Toronto
    Author: Paul Kongkham – University of Toronto
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-15 - Pilot study of high-dose pemetrexed for progressive chordoma
    Location: Exhibit Hall A/B
    Poster Presenter: Santosh Kesari – Pacific Neuroscience Institute
    Author: Naveed Wagle – Pacific Neuroscience Institute
    Author: Jose A. Carrillo – Pacific Neuroscience Institute
    Author: Akanksha Sharma – Pacific Neuroscience Institute/Saint John's Cancer Institute
    Author: Minhdan Nguyen, PA-C – Pacific Neuroscience Institute
    Author: Judy D. Truong, PA-C – Pacific Neuroscience Institute
    Author: Jaya Gill, MD, MHA – Pacific Neuroscience Institute
    Author: Raffi Nersesian – Saint John’s Cancer Institute at Providence Saint John’s Health Center
    Author: Natsuko Nomura – Pacific Neuroscience Institute
    Author: Elnaz Rahbarlayegh – Pacific Neuroscience Institute
    Author: Garni Barkhoudarian – Pacific Neuroscience Institute
    Author: Walavan Sivakumar – Pacific Neuroscience Institute
    Author: Daniel F. Kelly – Pacific Neuroscience Institute
    Author: Howard Krauss – Pacific Neuroscience Institute
    Author: Matias Bustos – Saint John’s Cancer Institute at Providence Saint John’s Health Center
    Author: Dave SB Hoon – Saint John’s Cancer Institute at Providence Saint John’s Health Center
    Author: Lars Anker – Providence St. Joseph Hospital Orange
    Author: Arun S. Singh – UCLA Health, Santa Monica Cancer Care
    Author: Kamalesh Sankhala – Cedars-Sinai, Samuel Oschin Cancer Center
    Author: Tiffany M. Juarez – Saint John’s Cancer Institute at Providence Saint John’s Health Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-16 - Use of predictive score-based historical control data in single-arm trials
    Location: Exhibit Hall A/B
    Poster Presenter: Wonsuk Yoo – Barrow Neurological Institute
    Author: William Kennedy – Barrow Neurological Institute
    Author: Amy Hong – Ivy Brain Tumor Center
    Author: Nader Sanai – Barrow Neurological Institute
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-17 - Application of the GBM-X Data Platform to estimate treatment effects of the experimental therapies of the randomized phase 2 Individualized Screening Trial of Innovative Glioblastoma Therapies
    Location: Exhibit Hall A/B
    Poster Presenter: Rifaquat Rahman – Department of Radiation Oncology, Dana-Farber/Brigham and Women’s Cancer Center, Boston, MA
    Author: Lorenzo Trippa – Dana Farber Cancer Institute
    Author: Geoffrey Fell – Dana-Farber Cancer Institute
    Author: Eudocia Q. Lee – Dana-Farber Cancer Institute, Boston, MA
    Author: Isabel Arrillaga-Romany – Massachusetts General Hospital
    Author: Mehdi Touat – Pitié Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Sorbonne Université
    Author: Jan Drappatz – University of Pittsburgh Medical Center
    Author: Mary R. Welch – Columbia University Irving Medical Center
    Author: Evanthia Galanis – Mayo Clinic
    Author: Manmeet S. Ahluwalia – Miami Cancer Institute, Baptist Health South Florida
    Author: Howard Colman – Huntsman Cancer Institute, University of Utah
    Author: Burt Nabors – Heersink School of Medicine
    Author: Jaroslaw Hepel – Rhode Island Hospital
    Author: Heinrich Elinzano – Rhode Island Hospital
    Author: David Schiff – University of Virginia School of Medicine
    Author: Ugonma N. Chukwueke – Dana-Farber Cancer Institute
    Author: Rameen Beroukhim – Center for Neuro-Oncology, Dana-Farber Cancer Institute
    Author: Lakshmi Nayak – Dana-Farber Cancer Institute
    Author: Jose Ricardo R. McFaline-Figueroa – Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA
    Author: Tracy T. Batchelor – Brigham and Women’s Hospital Harvard Medical School
    Author: Mikael Rinne – Dana-Farber Cancer Institute
    Author: Thomas Kaley – Memorial Sloan Kettering Cancer Center
    Author: Christine Lu-Emerson – Maine Health Maine Medical Center
    Author: Ingo K. Mellinghoff – Memorial Sloan Kettering Cancer Center
    Author: Wenya Linda Bi – Department of Neurosurgery, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Boston, MA
    Author: Omar Arnaout – Department of Neurosurgery, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Boston, MA
    Author: Pier Paolo Peruzzi – Brigham and Women's Hospital
    Author: Daphne Haas-Kogan – Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital
    Author: Shyam Tanguturi – Dana-Farber/Brigham and Women's Cancer Center
    Author: Daniel Cagney – Radiotherapy Department, Mater Private Network, Dublin, Ireland
    Author: Ayal Aizer – Dana-Farber/Brigham and Women's Cancer Center
    Author: Lisa Doherty – Dana-Farber Cancer Institute
    Author: Sandro Santagata – Brigham and Women's Hospital
    Author: David M. Meredith – Brigham and Women's Hospital
    Author: E. Antonio Chiocca – Brigham and Women's Hospital/ Harvard Medical School
    Author: David A. Reardon – Center for Neuro-Oncology, Dana-Farber Cancer Institute
    Author: Brian Alexander – Foundation Medicine
    Author: Keith L. Ligon – Brigham and Women's Hospital
    Author: Patrick Y. Wen – Dana-Farber Cancer Institute
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-18 - Designing and delivering a randomised controlled trial of medicinal cannabinoids in recurrent glioblastoma - the ARISTOCRAT trial
    Location: Exhibit Hall A/B
    Poster Presenter: Susan C. Short – St James's University Hospital, Leeds
    Author: Joshua Savage – University of Birmingham
    Author: Rhys Mant – University of Birmingham
    Author: Amit Patel – University of Birmingham
    Author: Peter Buckle – The Brain Tumour Charity
    Author: Sarah Meade – University Hospitals Birmingham
    Author: Florien W. Boele – University of Leeds
    Author: Emma Banks – St James's Hospital
    Author: Lucy Brazil – Guy's and St Thomas's Hospital
    Author: Fiona Collinson – St James's University Hospital, Leeds
    Author: Lucinda Billingham – University of Birmingham
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-19 - Resection and cesium-131 radiation sources imbedded in bio-resorbable collagen tiles (Gammatile™) followed by the Stupp protocol in newly-diagnosed glioblastoma: GESTALT trial-in-progress update
    Location: Exhibit Hall A/B
    Poster Presenter: Erin M. Dunbar – Piedmont Healthcare
    Author: Adam Nowlan – Piedmont Atlanta Hospital
    Author: David McCracken – Piedmont Atlanta Hospital
    Author: Karen L. Fink – Baylor Scott and White
    Author: Luke Lewis – Kettering Health
    Author: Mark Hoeprich – Kettering Health
    Author: Stuart Lee – ECU Health
    Author: Anthony Paravati – Kettering Health
    Author: Tolga Tuncer – KUMC
    Author: John David – USF
    Author: Divya Mella – Baylor Scott & White Health
    Author: Orwa Aboud – University of California Davis
    Author: Ruben Fragoso – 5. Department of Radiation Oncology, University of California Davis
    Author: Orin Bloch – Department of Neurological Surgery, University of California Davis
    Author: Clara Ferreira – University of Minnesota
    Author: Kathryn Dusenbery – University of Minnesota
    Author: Matthew Sean Peach – Vidant (ECU)
    Author: Eric Chang – USC Keck School of Medicine
    Author: David Brachman – GT Medical Technologies
    Author: Lisa Campbell – GT Medical Technologies
    Author: Clark C. Chen – University of Minnesota
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-20 - Nimotuzumab combined with concurrent chemoradiotherapy in the treatment of newly diagnosed pediatric diffuse intrinsic pontine glioma (DIPG)
    Location: Exhibit Hall A/B
    Author: Xiaoguang Qiu – Beijing Tiantan Hospital , Capital Medical University
    Author: Mawei Jiang – Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine
    Author: Chao Liu – Xiangya Hospital Central South University
    Author: Gang Wang – The Third People's Hospital of Zhengzhou
    Author: Rongjie Tao – Shandong Cancer Hospital & Institute
    Author: Jiankun Xu – Xuanwu Hospital Capital Medical University
    Author: Liangfang Shen – Xiangya Hospital Central South University
    Poster Presenter: Yanwei Liu – Beijing Tiantan Hospital, Capital Medical University
    Author: Heling Wang – The Third People's Hospital of Zhengzhou
    Author: Chuanying Zhu – Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine
    Author: Hui Zhang – Shandong Cancer Hospital & Institute
    Author: Gao Zeng – Xuanwu Hospital Capital Medical University
    Author: Jidong Hong – Xiangya Hospital Central South University
    Author: Baoshi Chen – Beijing Tiantan Hospital, Capital Medical University
    Author: Shujun Wang – The Third People's Hospital of Zhengzhou
    Author: Wenlan Bao – Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine
    Author: Jia Yang – Shandong Cancer Hospital & Institute
    Author: Qingtang Lin – Xuanwu Hospital Capital Medical University
    Author: Huan Li – Xiangya Hospital Central South University
    Author: Shuai Liu – Beijing Tiantan Hospital, Capital Medical University
    Author: Wei Zhang – The Third People's Hospital of Zhengzhou
    Author: Shuxian Chen – Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine
    Author: Yongrui Zhao – Xuanwu Hospital Capital Medical University
    Author: Jianbing Tang – Xiangya Hospital Central South University
    Author: Zhen Kou – The Third People's Hospital of Zhengzhou
    Author: Jun Su – Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine
    Author: Peng Sun – Xuanwu Hospital Capital Medical University
    Author: Longyun Wang – Xiangya Hospital Central South University
    Author: Xiaoyang Sun – Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine
    Author: Yan Ju – West China School of Medicine/West China Hospital of Sichuan University
    Author: Wenbin Ma – Peking Union Medical College Hospital
    Author: Yu Wang – Peking Union Medical College Hospital
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-26 - Efficacy and Safety of Metformin plus Low-Dose Temozolomide in Patients with Recurrent or Refractory Glioblastoma: A Randomized, Prospective, Multicenter, Double-Blind, Controlled, Phase 2 Trial
    Location: Exhibit Hall A/B
    Author: Wan Soo Yoon – Department of Neurosurgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea
    Author: Jong Hee Chang – Severance Hospital, Yonsei University College of Medicine
    Author: Jeong Hoon Kim – Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
    Author: Yu Jung Kim – Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
    Author: Tae Young Jung – Department of Neurosurgery, Chonnam National University Hwasun Hospital, Hwasun, Korea.
    Author: Heon Yoo – Department of Neuro-Oncology Clinic, Center for Specific Organs Cancer, National Cancer Center Hospital, National Cancer Center, Goyang, Korea.
    Author: Se-Hyuk Kim – Department of Neurosurgery, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea.
    Author: Do-Hyun Nam – Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
    Author: Tae Min Kim – Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
    Author: Se Hoon Kim – Yonsei University College of Medicine
    Author: Sung Hye Park – Department of Pathology, Seoul National University Hospital, Seoul, Korea.
    Author: Youn Soo Lee – Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Author: Hyeon Woo kim – Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Author: Yong-Kil Hong – Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Poster Presenter: Seung Ho Yang – Department of Neurosurgery, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-27 - Trial In Progress: A phase 2 study of BPM 31510 (an oxidized CoQ10-lipid conjugate nanodispersion) with vitamin K and standard chemoradiation in newly diagnosed glioblastoma
    Location: Exhibit Hall A/B
    Poster Presenter: Brian Stocksdale – Stanford University
    Author: Sophie Bertrand – Division of Neuro-oncology, Stanford University
    Author: Eleanor Villanueva – Division of Neuro-oncology, Stanford University
    Author: Lewis Naya – Division of Neuro-oncology, Stanford University
    Author: Donna Molaie – Department of Neurosurgery, Permanente Medical Group
    Author: Arianne Lyng – BPGbio
    Author: Brian Berman – BPGbio
    Author: Vivek K. Vishnudas – BPGbio
    Author: Michael A. Kiebish – BPGbio
    Author: Stephane Gesta – BPGbio
    Author: Niven R. Narain – BPGbio
    Author: Lawrence Recht – Division of Neuro-oncology, Stanford University
    Author: Seema Nagpal – Division of Neuro-oncology, Stanford University
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-28 - Final Results of a Pilot Study to Evaluate Infusion Rate Escalation to Maximize Volume of Distribution During Convection Enhanced Delivery to Contrast-Enhancing Glioblastoma
    Location: Exhibit Hall A/B
    Poster Presenter: James K. Liu – Department of Neurooncology/H. Lee Moffitt Cancer Center & Research Institute
    Author: Nam D. Tran – Moffitt Cancer Center
    Author: Cecily Piteo – Moffitt Cancer Center
    Author: Sebastian Matzza – Moffitt Cancer Center
    Author: Peter Forsyth – Moffitt Cancer Center
    Author: Michael A. A. Vogelbaum – Department of NeuroOncology, Moffitt Cancer Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-29 - A phase 2 study to evaluate efficacy and safety of ACT001 and temozolomide combination treatment in patients with recurrent glioblastoma multiforme
    Location: Exhibit Hall A/B
    Author: Wenbin Li – Tiantan Hospital
    Author: Qun Li – Wenzhou Medical University
    Author: Liang Wang – Tangdu Hospital
    Poster Presenter: Dongpo Cai – Accendatech USA Inc.
    Author: Xunjun Yang – Tianjin General Hospital
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-30 - Mesenchymal stem cell (MSC11FCD) based therapy elicited a favorable response with efficient 5-FU conversion in patients with recurrent glioblastoma: An open label, phase I/IIa trial
    Location: Exhibit Hall A/B
    Poster Presenter: Jaejoon Lim – Department of Neurosurgery, Bundang CHA Medical Center, CHA University College of Medicine
    Author: Da-Young Chang – Cellebrain research center
    Author: Jeongmin Sim – Department of Neurosurgery, Bundang CHA Medical Center, CHA University College of Medicine
    Author: Jin-Hwa Jung – Cellebrain research center
    Author: JeongMan Park – Department of Biomedical Science, College of Life Science, CHA University
    Author: Yu Jin Kim – Department of Neurosurgery, Bundang CHA Medical Center, CHA University College of Medicine
    Author: Dongkil Kim – Department of Neurosurgery, Bundang CHA Medical Center, CHA University College of Medicine
    Author: Sojung Hwang – Global Research Supporting Center, Bundang CHA Medical Center, CHA University
    Author: Sung-Soo Kim – Department of Anatomy, Ajou University School of Medicine
    Author: Hea-Young Cho – College of Pharmacy, CHA University
    Author: Haeyoung Suh-Kim – Department of Anatomy, Ajou University School of Medicine
    Author: Kyunggi Cho – Department of Neurosurgery, Bundang CHA Medical Center, CHA University College of Medicine
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-31 - Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status
    Location: Exhibit Hall A/B
    Poster Presenter: Jonathan Weller – Department of Neurosurgery, University Hospital, LMU Munich
    Author: Sophie Katzendobler – Department of Neurosurgery, University Hospital, LMU Munich
    Author: Sebastian Niedermeyer – Department of Neurosurgery, University Hospital, LMU Munich
    Author: Patrick N. Harter – Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany
    Author: Jochen Herms – Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany
    Author: Christoph Trumm – Department of Neuroradiology, LMU Munich, Munich, Germany
    Author: Maximilian Niyazi – Department of Radiation Oncology, Munich University Hospital, LMU Munich, Munich, Germany
    Author: Niklas Thon – Department of Neurosurgery, University Hospital, LMU Munich
    Author: Joerg-Christian Tonn – Department of Neurosurgery, University Hospital, LMU Munich
    Author: Veit M. Stoecklein – Department of Neurosurgery, University Hospital, LMU Munich
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-32 - Implementing genomic profiling as standard-of-care for glioblastoma patients.
    Location: Exhibit Hall A/B
    Poster Presenter: Vincent N. Fougner – The DCCC Brain Tumor Center
    Author: Thomas Urup – The DCCC Brain Tumor Center, Rigshospitalet
    Author: Benedikte Hasselbalch – The DCCC Brain Tumor Center, Rigshospitalet
    Author: Hans Skovgaard Poulsen – The DCCC Brain Tumor Center
    Author: Kristoffer Rohrberg – Phase 1 unit, Dept. of Oncology, Rigshospitalet, Denmark
    Author: Iben Spanggard – Phase 1 unit, Dept. of Oncology, Rigshospitalet, Denmark
    Author: Martin Højgaard – Phase 1 unit, Dept. of Oncology, Rigshospitalet, Denmark
    Author: Laila Belcaid – Phase 1 unit, Dept. of Oncology, Rigshospitalet, Denmark
    Author: Christina Westmose Yde – Center for Genomic Medicine, Rigshospitalet, Denmark
    Author: Ulrik N. Lassen – Department of Oncology, Rigshospitalet, University Hospital Copenhagen
    Author: Dorte Noeroexe – DCCC - Brain Tumor Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-33 - TARGET trial: a phase I/II open-label multicenter study to assess safety, tolerability, and clinical efficacy of AZD4547 in patients with relapsed/refractory FGFR fusion positive glioma
    Location: Exhibit Hall A/B
    Poster Presenter: Alberto Picca – Paris Brain Institute
    Author: Anna Luisa Di Stefano – Department of Neurosurgery, Azienda Ospedaliera Toscana Nord-ovest, Livorno, Italy
    Author: Julien Savatovsky – Hôpital Fondation A. de Rothschild
    Author: Francois Ducray – Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon
    Author: Olivier Chinot – University Hospital Timone
    Author: Elisabeth Cohen-Jonathan Moyal – Cancer University Institute of Toulouse
    Author: Paule Augereau – Institut de Cancérologie de L'ouest- Paul Papin
    Author: Yohann Schmitt – Paris Brain Institute
    Author: Julie Lerond – Paris Brain Institute
    Author: Nabila Rousseaux – Pitié-Salpêtrière Hospital
    Author: Christine Fardeau – Pitié-Salpêtrière Hospital
    Author: Karima Mokhtari – Pitie Salpetriere Hospital
    Author: Franck Bielle – Pitie Salpetriere Hospital
    Author: David Meyronet – Hospices Civils de Lyon
    Author: Antonio Iavarone – University of Miami
    Author: Marc Sanson – Pitie Salpetriere Hospital
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-34 - Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: final results of the EORTC 1608 STEAM trial
    Location: Exhibit Hall A/B
    Poster Presenter: Emilie Le Rhun – Departments of Neurosurgery and Neurology, University Hospital and University of Zurich
    Author: Thierry Gorlia – EORTC headquarter
    Author: Jörg Felsberg – Heinrich Heine University and University Hospital Düsseldorf
    Author: Julia Furtner – Medical University of Vienna
    Author: Joost LM Jongen – Erasmus MC Cancer Institute
    Author: Claude-Alain Maurage – University of Lille
    Author: Francois Ducray – Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon
    Author: Patrick Roth – Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland
    Author: Peter Hau – Department of Neurology and Wilhelm Sander-NeuroOncology Unit, University Hospital Regensburg
    Author: Olivier Chinot – University Hospital Timone
    Author: Matthias Preusser – Medical University of Vienna
    Author: Stephanie Cartalat – Neurological Hospital
    Author: Martin J. van den Bent – Erasmus MC Cancer Institute
    Author: Maike Collienne – EORTC headquarter
    Author: Guido Reifenberger – Institute of Neuropathology, Heinrich Heine University Medical Faculty and University Hospital Düsseldorf
    Author: Michael Weller – Department of Neurology and Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-35 - A randomized, controlled trial of Berubicin vs. Lomustine after first-line therapy for Glioblastoma Multiforme (GBM): Interim results of a pre-planned analysis of overall survival (OS)
    Location: Exhibit Hall A/B
    Poster Presenter: Sandra L. Silberman – CNS Pharmaceuticals
    Author: Zena Muzyczenko – CNS Pharmaceuticals
    Author: Sigmund Hsu – University of Texas Health Science Center at Houston
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-36 - Sacituzumab govitecan for recurrent glioblastoma
    Location: Exhibit Hall A/B
    Poster Presenter: William Kelly – Mays Cancer Center
    Author: Henriette U. Balinda – UT Health San Antonio
    Author: Pegah Ghamasaee – UT health science center San Antonio
    Author: Andrea Gilbert – University of Texas Health Science Center at San Antonio & University Hospital
    Author: Joel Michalek – UT Health San Antonio Mays Cancer Center
    Author: Prathibha Surapaneni – Mays Cancer Center
    Author: John Floyd – UT Health Science Center San Antonio
    Author: Andrew J. Brenner – UT Health San Antonio Mays Cancer Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-38 - RACTAC trial: Phase II multicentric italian trial on Repositioning of the Antipsychotic drug Chlorpromazine and its combination with Temozolomide in MGMT unmethylated glioblastoma patients
    Location: Exhibit Hall A/B
    Poster Presenter: Andrea Pace – Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute
    Author: Giuseppe Lombardi – Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS
    Author: Veronica Villani – Neuro-Oncology, IRCCS-Regina Elena National Cancer Institute
    Author: Dario Benincasa – IRCCS Regina Elena National Cancer Institute
    Author: Claudia Abruzzese – IRCCS Regina Elena National Cancer Institute
    Author: Ilaria Cestonaro – Veneto Institute of Oncology IOV-IRCCS
    Author: Martina Corrà – Veneto Institute of Oncology IOV-IRCCS
    Author: Giulia Cerretti – Veneto Institute of Oncology IOV-IRCCS
    Author: Mario Caccese – Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS
    Author: Antonio Silvani – Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
    Author: Paola Gaviani – Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico C. Besta
    Author: Diana Giannarelli – Biostatistics Unit, Scientific Directorate, Fondazione Policlinico Universitario A. Gemelli, IRCCS
    Author: Marco Giorgio Paggi – IRCCS Regina Elena National Cancer Institute
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-39 - REGOMA-OS: a large Italian multicenter, prospective, observational study analyzing regorafenib efficacy and safety in recurrent glioblastoma patients
    Location: Exhibit Hall A/B
    Author: Mario Caccese – Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS
    Author: Isacco Desideri – Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence
    Author: Veronica Villani – Neuro-Oncology, IRCCS-Regina Elena National Cancer Institute
    Author: Matteo Simonelli – Oncology Department, IRCCS Humanitas Research Hospital
    Author: Michela Buglione – Department of Radiation Oncology, University and Spedali Civili Hospital
    Author: Silvia Chiesa – UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS
    Author: Enrico Franceschi – Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna
    Author: Paola Gaviani – Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico C. Besta
    Author: Irene Stasi – Medical Oncology Department, Istituto Toscano Tumori, Ospedale Civile
    Author: Claudia Caserta – Medical Oncology Unit, Azienda Ospedaliera S. Maria
    Author: Sonia Brugnara – Department of Medical Oncology, Santa Chiara Hospital
    Author: Ivan Lolli – Oncology Unit of National Institute of Gastroenterology "S. de Bellis", Research Hospital
    Author: Elisa Bennicelli – Oncology Unit, IRCCS Ospedale Policlinico San Martino
    Author: Paola Bini – IRCCS "C. Mondino" Foundation, National Neurological Institute
    Author: Angelo Salvatore Cuccu – Department of Oncology, Azienda Ospedaliero Universitaria di Sassari
    Author: Silvia Scoccianti – Radiation Oncology Unit, Santa Maria Annunziata Hospital
    Author: Giovanna Magni – Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS
    Author: Gian Luca De Salvo – Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS
    Author: Vittorina Zagonel – Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS
    Poster Presenter: Giuseppe Lombardi – Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-40 - A multicenter, retrospective analysis of prognostic factors in intracranial H3 K27M-mutant diffuse midline glioma in adults
    Location: Exhibit Hall A/B
    Poster Presenter: Alice Senta Ryba – Department of Neurosurgery, University medical center Hamburg Eppendorf
    Author: Zeynep Özdemir – University Hospital Münster, Germany
    Author: Nitzan Nissimov – Charité - University Hospital Berlin, Germany
    Author: Lisa Hönikl – Technical University Munich, Germany
    Author: Nicolas Noel Neidert – University of Freiburg; Germany
    Author: Martin Jakobs – University Hospital Heidelberg, Germany
    Author: Darius Kalasauskas – University Medical Center Mainz, Germany
    Author: Aleksandrs Krigers – Medical University Innsbruck, Austria
    Author: Christian F. Freyschlag – Medical University Innsbruck
    Author: Florian Ringel – University Medical Center Mainz, Germany
    Author: Philip Dao Trong – University Hospital Heidelberg, Germany
    Author: Dieter Henrik H. Heiland – University of Freiburg; Germany
    Author: Jens Gempt – Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Germany
    Author: Julia Onken – Charité - University Hospital Berlin, Germany
    Author: Eric Suero Molina – Department of Neurosurgery, University Hospital of Münster, Münster, Germany
    Author: Manfred Westphal – Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Germany
    Author: Ulrich Schüller – University Medical Center Hamburg-Eppendorf, Germany
    Author: Malte Mohme – Department of Neurosurgery, University Medical Centre Hamburg-Eppendorf, Germany
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-42 - Phase I clinical trial of peposertib plus radiation in newly diagnosed MGMT-unmethylated glioblastoma
    Location: Exhibit Hall A/B
    Poster Presenter: Nazanin K. Majd – University of Texas MD Anderson Cancer Center
    Author: D. Nana Yeboa – The University of Texas MD Anderson Cancer Center
    Author: Shiao-Pei Weathers – University of Texas MD Anderson Cancer Center
    Author: Ying Yuan – University of Texas MD Anderson Cancer Center
    Author: Christine Robichaux – MD Anderson
    Author: Haider Al Anssari – MD Andereson
    Author: Evguenia Gachimova – University of Texas MD Anderson Cancer Center
    Author: Monica Loghin – University of Texas MD Anderson Cancer Center
    Author: Carlos Kamiya-Matsuoka – MD Anderson Cancer Center
    Author: Barbara J. O'Brien – University of Texas MD Anderson Cancer Center
    Author: Ashley E. Aaroe – University of Texas MD Anderson Cancer Center
    Author: Chirag B. Patel – University of Texas MD Anderson Cancer Center
    Author: W.K. Alfred Yung – University of Texas MD Anderson Cancer Center
    Author: Max wintermark – MD Anderson
    Author: Maria Gule – The University of Texas MD Anderson Cancer Center
    Author: Sherise D. Ferguson – The University of Texas MD Anderson Cancer Center
    Author: Vinay K. Puduvalli – University of Texas MD Anderson Cancer Center
    Author: John F. de Groot – University of California, San Francisco
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-43 - A Phase 1/2 Study of Low Dose Fractionated Radiation Therapy as a Chemopotentiator of Salvage Temozolomide for High-Grade Glioma
    Location: Exhibit Hall A/B
    Author: Timothy Lin – Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine
    Author: Suqi Ke – Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine
    Author: Chen Hu – Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine
    Author: Debraj Mukherjee – Department of Neurosurgery, Johns Hopkins University School of Medicine
    Author: Jon Weingart – Department of Neurosurgery, Johns Hopkins University School of Medicine
    Author: Lawrence Richard Kleinberg – Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine
    Author: James Huang – Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine
    Author: Ryan Assadi – Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine
    Author: Matthias Holdhoff – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Author: Stuart A. Grossman – Department of Oncology, Johns Hopkins University School of Medicine
    Author: Mansoor Ahmed – National Cancer Institute
    Poster Presenter: Kristin Redmond – Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-44 - Neoadjuvant treatment with ST101, C/EBPβ antagonist, triggers necrosis as a pathological response in newly diagnosed GBM patients. Tissue-based analysis from a surgical window of opportunity trial.
    Location: Exhibit Hall A/B
    Poster Presenter: Fabio M. Iwamoto – Division of Neuro-Oncology, New York-Presbyterian/Columbia University Medical Center
    Author: Abi Vainstein-Haras – Sapience Therapeutics
    Author: Jim Rotolo – Sapience Therapeutics
    Author: Clara Levrero – Columbia University
    Author: Robert Michel – Bexon Clinical Consultants
    Author: Nicolas Kostelecky – Northwestern Medicine - CDH Cancer Center
    Author: Anastasia Papaioannou – Northwestern Medicine - CDH Cancer Center
    Author: Robin Buerki – Northwestern Medicine - CDH Cancer Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-45 - Upfront chemotherapy and subsequent resection utilizing neoadjuvant strategy for oligodendrogliomas
    Location: Exhibit Hall A/B
    Poster Presenter: Hikaru Sasaki – Tokyo Dental College Ichikawa General Hospital, Department of Neurosurgery
    Author: Yohei Kitamura – Keio University School of Medicine
    Author: Masahiro Toda – Keio University School of Medicine
    Author: Yuichi Hirose – Fujita Health University School of Medicine
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-46 - Upfront versus deferred treatment in lower grade IDH-mutant gliomas: a single-center retrospective analysis 
    Location: Exhibit Hall A/B
    Poster Presenter: Anuj D. Patel – MD Anderson Cancer Center
    Author: Benjamin Whitfield – MD Anderson Cancer Center
    Author: Leomar Ballester – Department of Pathology, The University of Texas MD Anderson Cancer Center
    Author: Vinay K. Puduvalli – University of Texas MD Anderson Cancer Center
    Author: Carlos Kamiya-Matsuoka – MD Anderson Cancer Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-47 - Dose escalation of ASTX727 in adult patients with recurrent/progressive non-enhancing IDH mutant gliomas
    Location: Exhibit Hall A/B
    Poster Presenter: Isabel Arrillaga-Romany – Massachusetts General Hospital
    Author: Julie J. Miller – Massachusetts General Hospital
    Author: Jorg Dietrich – Dept. of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Author: Scott R. Plotkin – Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Author: Elizabeth R. Gerstner – Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Author: Justin T. T. Jordan – Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Author: Deborah A. Forst – Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Author: Eudocia Q. Lee – Dana-Farber Cancer Institute, Boston, MA
    Author: Patrick Y. Wen – Dana-Farber Cancer Institute
    Author: David A. Reardon – Center for Neuro-Oncology, Dana-Farber Cancer Institute
    Author: Lakshmi Nayak – Dana-Farber Cancer Institute
    Author: Tracy T. Batchelor – Brigham and Women’s Hospital Harvard Medical School
    Author: Ugonma N. Chukwueke – Dana-Farber Cancer Institute
    Author: Miguel N. Rivera – MASSACHUSETTS GENERAL HOSPITAL
    Author: Nathalie Y.R. Agar – Brigham and Women's Hospital
    Author: Daniel P. Cahill – Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School
    Author: Bradley Bernstein – Dana Farber Cancer Institute
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-48 - Survival, Toxicity, and Patient Reported QoL Outcomes Following Pulsed Reduced Dose Rate Re-Irradiation with Concurrent Bevacizumab for Recurrent Grade 4 Gliomas: Results of a Phase II Study
    Location: Exhibit Hall A/B
    Poster Presenter: Brett A. Morris – University of Wisconsin
    Author: Adam R. Burr – University of Wisconsin
    Author: Marissa Weiss – University of Wisconsin
    Author: Nicholas Anger – University of Wisconsin
    Author: Colin Harari – University of Wisconsin
    Author: Wolfgang A. Tomé – Albert Einstein College of Medicine
    Author: Robert A. Bayliss – University of Wisconsin
    Author: Ankush Bhatia – Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health
    Author: Patrick Grogan – University of Wisconsin
    Author: Henry I. Robins – University of Wisconsin
    Author: Steven P. Howard – University of Wisconsin
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-49 - Rhenium-(Re-186)-obisbemeda [Re-186-nanoliposome] (186RNL) Phase 2 for recurrent glioblastoma (rGBM) via Convection Enhance Delivery [CED]
    Location: Exhibit Hall A/B
    Poster Presenter: Andrew J. Brenner – UT Health San Antonio Mays Cancer Center
    Author: Joel Michalek – UT Health San Antonio Mays Cancer Center
    Author: Melissa Moore – PLUS Therapeutics
    Author: Marc Hedrick – PLUS Therapeutics
    Author: Ande Bao – Case Western Reserve University
    Author: William T. Phillips – UT Health San Antonio Mays Cancer Center
    Author: Toral R. Patel – UT Southwestern Medical Center
    Author: Jeffrey S. Weinberg – MD Anderson Cancer Center
    Author: John Floyd – UT Health Science Center San Antonio
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-50 - Update Report of the ReSPECT-GBM Phase I/IIa Dose Escalation Trial of Rhenium-186 NanoLiposome (186RNL) in Recurrent Glioma [rGBM] via Convection Enhanced Delivery (CED)
    Location: Exhibit Hall A/B
    Poster Presenter: Andrew J. Brenner – UT Health San Antonio Mays Cancer Center
    Author: Joel Michalek – UT Health San Antonio Mays Cancer Center
    Author: Melissa Moore – PLUS Therapeutics
    Author: Marc Hedrick – PLUS Therapeutics
    Author: Ande Bao – Case Western Reserve University
    Author: William T. Phillips – UT Health San Antonio Mays Cancer Center
    Author: Toral R. Patel – UT Southwestern Medical Center
    Author: Jeffrey S. Weinberg – MD Anderson Cancer Center
    Author: John Floyd – UT Health Science Center San Antonio
    Author: Michael Youssef – UT Southwestern Medical Center
    Author: Shiliang Huang – UT Health San Antonio Mays Cancer Center
    Author: Norman LaFrance – PLUS Therapeutics
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-52 - Survival Outcomes in Recurrent Glioblastoma (rGBM) Patients Treated with a Single Intra-tumoral Administration of Bizaxofusp, an IL-4R-targeting Toxin, in a Phase IIb Trial
    Location: Exhibit Hall A/B
    Author: John H. Sampson – Duke University
    Author: Achal Singh Achrol – Loma Linda University Medical Center
    Author: Manish K. Aghi – University of California, San Francisco
    Author: Krystof Bankiewicz – Ohio State University College of Medicine
    Author: Martin Bexon – Medicenna Therapeutics
    Poster Presenter: Steven Brem – University of Pennsylvania
    Author: Andrew J. Brenner – UT Health San Antonio Mays Cancer Center
    Author: Sajeel Chowdhary – Boca Raton Regional Hospital
    Author: Melissa Coello – Medicenna Therapeutics
    Author: Annick Desjardins – Duke University
    Author: Benjamin M. Ellingson – UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, University of California Los Angeles
    Author: John Floyd – UT Health Science Center San Antonio
    Author: Seunggu Han – Stanford University
    Author: Santosh Kesari – Pacific Neuroscience Institute
    Author: Yael Mardor – The Advanced Technology Center, Sheba Medical Center
    Author: Fahar Merchant – Medicenna Therapeutics
    Author: Rosemina Merchant – Medicenna Therapeutics
    Author: Dina Randazzo – Duke University Medical Center
    Author: Michael A. A. Vogelbaum – Department of NeuroOncology, Moffitt Cancer Center
    Author: Frank Vrionis – Boca Raton Regional Hospital
    Author: Eva Wembacher-Schroeder – Brainlab AG
    Author: Minh D. To – Medicenna Therapeutics
    Author: Miroslaw Zabek – Mazovian Bronowski Hospital
    Author: Nicholas A. Butowski – University of California San Francisco
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-53 - Establishing a phase I and randomized phase II trial of selinexor and temozolomide in glioblastoma
    Location: Exhibit Hall A/B
    Poster Presenter: Frances Chow – University of Southern California, Norris Comprehensive Cancer Center
    Author: Michael Berens – Translational Genomics Research Institute
    Author: Sharon Tamir – Karyopharm
    Author: Yosef Landesman – Karyopharm
    Author: Christopher Walker – Karyopharm
    Author: Joycelynne Palmer – City of Hope Comprehensive Cancer Center
    Author: Alyx B. Porter – Mayo Clinic Arizona
    Author: David Piccioni, MD, PhD – University of California San Diego Health
    Author: Douglas Ney – University of Colorado
    Author: Macarena I. de la Fuente – Sylvester Comprehensive Cancer Center
    Author: Sani H. Kizilbash – Mayo Clinic (Rochester)
    Author: Kimberly Bojanowski-Hoang – Emory University Hospital
    Author: Lindsay Lipinski – Roswell Park Cancer Institute
    Author: Roy E. Strowd – Wake Forest University School of Medicine
    Author: Pierre Giglio – The Ohio State University Wexner Medical Center
    Author: Maya Hrachova – University of Oklahoma
    Author: Megan M. Mantica – University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center
    Author: David Schiff – University of Virginia School of Medicine
    Author: Steven Gore – National Cancer Institute
    Author: Jana L. Portnow – Department of Medical Oncology, City of Hope Beckman Research Institute
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-55 - A multicenter study of low-intensity focused ultrasound with systemic microbubble oscillators for blood-brain barrier disruption for liquid biopsy in glioblastoma (LIBERATE)
    Location: Exhibit Hall A/B
    Poster Presenter: Manmeet S. Ahluwalia – Miami Cancer Institute, Baptist Health South Florida
    Author: Michael W. McDermott – Miami Neuroscience Institute
    Author: Terry C. Burns – Mayo Clinic Rochester
    Author: John F. de Groot – University of California, San Francisco
    Author: Alon Mogilner – NYU Langone
    Author: Achal Achrol – Insightec Inc.
    Author: Bhavya Shah – University of Texas Southwestern
    Author: Chetan Bettegowda – Johns Hopkins Medical Institutes
    Author: Ahmad Ozair – Miami Cancer Institute, Baptist Health South Florida
    Author: Atulya Khosla – Miami Cancer Institute, Baptist Health South Florida
    Author: Theodore H. Schwartz – Weill Cornell Medicine
    Author: Arjun Sahgal – Sunnybrook Health Sciences Centre
    Author: Mark V V. Mishra – Maryland Proton Treatment Center
    Author: Richard G. Everson – University of California; Los Angeles
    Author: Jeffrey S. Weinberg – MD Anderson Cancer Center
    Author: Nduka Amankulor – University of Pennsylvania
    Author: Justin Sporrer – Miami Neuroscience Institute, Baptist Health South Florida
    Author: Christopher P. Cifarelli – West Virginia University
    Author: Ali Rezai – Rockefeller Neuroscience Institute, West Virginia University
    Author: Nir Lipsman – Sunnybrook Health Sciences Centre
    Author: Graeme F Woodworth – University of Maryland School of Medicine
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-56 - Feasibility and efficacy of AI-guided personalized precision radiation therapy in newly diagnosed glioblastoma: a matched-control study
    Location: Exhibit Hall A/B
    Poster Presenter: Hamed Akbari – Santa Clara University
    Author: Suyash Mohan – University of Pennsylvania
    Author: Anahita Fathi Kazerooni – University of Pennsylvania, USA
    Author: Michel Bilello – University of Pennsylvania
    Author: Chiharu Sako – University of Pennsylvania
    Author: Jose A. Garcia – University of Pennsylvania
    Author: Cecilia Jiang – University of Pennsylvania
    Author: Fang Liu – University of Pennsylvania
    Author: Steven Brem – University of Pennsylvania
    Author: Spyridon Bakas – Indiana University
    Author: Saima Rathore – Avid Radiopharmaceuticals
    Author: Elizabeth Mamourian – University of Pennsylvania, USA
    Author: Abigail Pepin – University of Pennsylvania
    Author: Paul James – University of Pennsylvania
    Author: Jay F Dorsey – University of Pennsylvania
    Author: Ashish Singh – University of Pennsylvania
    Author: Drew Parker – University of Pennsylvania
    Author: Ragini Verma – University of Pennsylvania
    Author: Quy Cao – University of Pennsylvania
    Author: Russell T Shinohara – University of Pennsylvania
    Author: Stephen J. Bagley – University of Pennsylvania
    Author: Arati S. Desai – University of Pennsylvania
    Author: Donald M M. O'Rourke – University of Pennsylvania
    Author: MacLean P. Nasrallah – University of Pennsylvania, USA
    Author: Michelle Alonso-Basanta – University of Pennsylvania
    Author: Boon-Keng Kevin Teo – University of Pennsylvania
    Author: Goldie Kurtz – University of Pennsylvania
    Author: Gaurav Shukla – University of Pennsylvania
    Author: Robert A A. Lustig – University of Pennsylvania
    Author: Christos Davatzikos – University of Pennsylvania, USA
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-57 - Preliminary results of a Phase 1 trial of oral gallium maltolate in recurrent glioblastoma
    Location: Exhibit Hall A/B
    Poster Presenter: Jennifer M. Connelly – Medical College of Wisconsin
    Author: Casey Zoss – Medical College of Wisconsin
    Author: Kathleen M. Schmainda – Medical College of Wisconsin
    Author: Mona M. Al-Gizawiy – Medical College of Wisconsin
    Author: Fernando Santos Pinheiro – Medical College of Wisconsin
    Author: Christopher R. Chitambar – Medical College of Wisconsin
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-59 - Rare and novel KIAA1549-BRAF fusion breakpoints predict poor clinical outcome for patients with recurrent or progressive pediatric low-grade glioma: phase II PNOC001 trial results.
    Location: Exhibit Hall A/B
    Poster Presenter: Sebastian M. Waszak – École Polytechnique Fédérale de Lausanne (EPFL)
    Author: Mariam Aboian – Yale School of Medicine
    Author: Jane Minturn – Children’s Hospital of Philadelphia
    Author: Sarah E. S. Leary – Cancer and Blood Disorders Center, Seattle Children's
    Author: Mohamed S. S. Abdelbaki – St. Louis Children's Hospital (NCH)
    Author: Stewart Goldman – University of Arizona
    Author: Jennifer Elster – University of California, San Diego
    Author: Adam Kraya – Children's Hospital of Philadelphia
    Author: Matthew Lueder – Children’s Hospital of Philadelphia
    Author: Divya Ramakrishnan – Department of Radiology and Biomedical Imaging, Yale School of Medicine
    Author: Marc von Reppert – Department of Radiology and Biomedical Imaging, Yale School of Medicine
    Author: Kevin Liu – Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital
    Author: Adam Resnick – Children's Hospital of Philadelphia
    Author: David A. Solomon – University of California, San Francisco
    Author: Annette M. Molinaro – University of California, San Francisco
    Author: Joanna J. Phillips – University of California, San Francisco
    Author: Michael Prados – University of California, San Francisco
    Author: Daphne Haas-Kogan – Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital
    Author: Sabine Mueller – University of California, San Francisco
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-60 - Treatment of recurrent glioblastoma with APG-157 via expanded access: preliminary results from six patients from a single-center study
    Location: Exhibit Hall A/B
    Poster Presenter: Ekokobe Fonkem – Medical College of Wisconsin
    Author: Colton Betts – Texas A&M University School of Medicine
    Author: Eva Bradshaw – University of North Texas
    Author: Adam Tamini – Baylor Scott and White
    Author: Elizabeth Anyanda – Baylor Scott and Whilte Healthcare System
    Author: Parag Mehta – Aveta Biomics
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-62 - Interim data on dual inhibition of post-radiogenic angio-vasculogenesis by olaptesed pegol (NOX-A12) and bevacizumab in glioblastoma from the first expansion arm of the phase 1/2 GLORIA trial.
    Location: Exhibit Hall A/B
    Poster Presenter: Frank A. Giordano – Department of Radiation Oncology, University Medical Center Mannheim
    Author: Julian P. Layer – Department of Radiation Oncology, University Hospital Bonn
    Author: Sonia Leonardelli – Institute of Experimental Oncology, University Hospital Bonn
    Author: Lea L. Friker – Institute of Neuropathology, University Hospital Bonn
    Author: Christina Schaub – Division of Neurooncology, Department of Neurology, University Hospital Bonn
    Author: Thomas Zeyen – Division of Neurooncology, Department of Neurology, University Hospital Bonn
    Author: Elena Sperk – Department of Radiation Oncology, Medical Faculty Mannheim, University of Heidelberg
    Author: Peter Hambsch – Department of Radiotherapy, University Hospital Leipzig
    Author: Christoph Oster – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Franziska Grau – Department of Neuroradiology, University Hospital Bonn
    Author: Daniel Paech – Department of Neuroradiology, University Hospital Bonn
    Author: Wolf Müller – Institute of Neuropathology, University Hospital Leipzig
    Author: Torsten Pietsch – University Hospital Bonn
    Author: L. Christopher Schmeel – Department of Radiation Oncology, University Hospital Bonn
    Author: Oliver Grauer – Department of Neurology, University Hospital Münster
    Author: Mirjam Renovanz – Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research
    Author: Ghazaleh Tabatabai – University Hospital Tübingen and Eberhard Karls University Tübingen
    Author: Sied Kebir – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Sotirios Bisdas – Department of Neuroradiology at the National Hospital for Neurology, London
    Author: Erdem Güresir – Department of Neurosurgery, University Hospital Leipzig
    Author: Martin Glas – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Clemens Seidel – Department of Radiotherapy and Radiation Oncology, University Hospital Leipzig, Leipzig, Germany
    Author: Michael Hölzel – Institute of Experimental Oncology, University Hospital Bonn
    Author: Ulrich Herrlinger – Division of Clinical Neurooncology, Department of Neurology and Center for Integrated Oncology, University Hospital Bonn, Bonn, Germany
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-63 - A phase IIa clinical trial for Combination of navigation-guide focused ultrasound and bevacizumab for patients with recurrent glioblastoma
    Location: Exhibit Hall A/B
    Poster Presenter: Kuo-Chen Ｗei – New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation)
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-65 - Investigating safety and efficacy of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma - first results of the PriCoTTF phase I/II trial
    Location: Exhibit Hall A/B
    Poster Presenter: Sied Kebir – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Lazaros Lazaridis – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Teresa Schmidt – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Christoph Oster – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Jonas Feldheim – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen
    Author: Daniela Pierscianek – Department of Neurosurgery and Spine Surgery, University Medicine Essen
    Author: Martin A. Proescholdt – University Regensburg Medical Center, Department of Neurosurgery
    Author: Peter Hau – Department of Neurology and Wilhelm Sander-NeuroOncology Unit, University Hospital Regensburg
    Author: Anca-Ligia Grosu – Department of Radiation Oncology, Medical Center - University of Freiburg
    Author: Dietmar Krex – Department of Neurosurgery, University Hospital Carl Gustav Carus, Technical University Dresden
    Author: Ulrich Sure – Department of Neurosurgery and Spine Surgery, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Björn Scheffler – German Cancer Research Center (DKFZ), Heidelberg, Germany
    Author: Christoph Kleinschnitz – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Christoph Pöttgen – Department of Radiotherapy, University Medicine Essen
    Author: Martin Stuschke – Department of Radiotherapy, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Martin Glas – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-66 - Decoding Glioblastoma Survival: Unraveling the Prognostic Potential of Olfactory Function in a Prospective Observational Study
    Location: Exhibit Hall A/B
    Poster Presenter: Christoph Oster – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Thomas Hummel – Department of Otorhinolaryngology, Smell and Taste Clinic, TU Dresden, Dresden, Germany
    Author: Elke Hattingen – Department of Neuroradiology, Goethe University Hospital, Frankfurt am Main, Germany
    Author: Teresa Schmidt – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Lazaros Lazaridis – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Daniel Jokisch – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Martha Jokisch – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Sarina Agkatsev – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Yahya Ahmadipour – Department of Neurosurgery and Spine Surgery, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Ulrich Sure – Department of Neurosurgery and Spine Surgery, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Martin Stuschke – Department of Radiotherapy, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Christoph Kleinschnitz – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Björn Scheffler – German Cancer Research Center (DKFZ), Heidelberg, Germany
    Author: Cornelius Deuschl – Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Sied Kebir – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Author: Martin Glas – Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-68 - Phase I/II Study of Maintenance Therapy with Metformin and Temozolomide for Targeting Glioblastoma Cancer Stem Cells
    Location: Exhibit Hall A/B
    Poster Presenter: YOSHITAKA NARITA – National Cancer Center Hospital
    Author: Makoto Ohno – Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital,
    Author: Chifumi Kitanaka – Department of Molecular Cancer Science, Faculty of Medicine, Yamagata University
    Author: Shota Tanaka – The University of Tokyo Hospital
    Author: Yukihiko Sonoda – Yamagata University
    Author: Kazuhiko Mishima – Department of Neuro-Oncology/Neurosurgery, International Medical Center, Saitama Medical University
    Author: Eiichi Ishikawa – University of Tsukuba
    Author: Ken Ohashi – Department of General Internal Medicine, National Cancer Center Hospital, Tokyo,
    Author: Motoo Nagane – Department of Neurosurgery, Kyorin University Faculty of Medicine
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-70 - Radiotherapy quality assurance in the ROAM/EORTC1308 atypical meningioma randomised controlled trial: prospective review improves radiotherapy quality and consistency
    Location: Exhibit Hall A/B
    Poster Presenter: Michael D. Jenkinson – University of Liverpool
    Author: Helen Mayles – Clatterbridge Cancer Centre
    Author: Damien C. Weber – Paul Scherrer Institute
    Author: Brian J. Haylock – Clatterbridge Cancer Centre
    Author: ROAM/EORTC1308 Trial Management Group – University of Liverpool
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-72 - Phase II Trial of Pathology-based Three-group Treatment Stratification for Patients With CNS Germ Cell Tumors: A Long-term Follow-up Study
    Location: Exhibit Hall A/B
    Poster Presenter: Hirokazu Takami – The University of Tokyo Hospital
    Author: Tomonari Suzuki – Saitama Medical University International Medical Center
    Author: Kazuhiko Takabatake – Saitama Medical University Hospital
    Author: Takamitsu Fujimaki – Saitama Medical University Hospital
    Author: Michinari Okamoto – Hokkaido University School of Medicine
    Author: Shigeru Yamaguchi – Hokkaido University Graduate School of Medicine
    Author: Masayuki Kanamori – Tohoku University Graduate School of Medicine
    Author: Kenichiro Matsuda – Yamagata University
    Author: Yukihiko Sonoda – Yamagata University
    Author: Manabu Natsumeda – Niigata University Brain Research Institute
    Author: Junya Ichinose – Kanazawa University
    Author: Mitsutoshi Nakada – Department of Neurosurgery, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
    Author: Ai Muroi – University of Tsukuba
    Author: Eiichi Ishikawa – University of Tsukuba
    Author: Masamichi Takahashi – Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital
    Author: YOSHITAKA NARITA – National Cancer Center Hospital
    Author: Fumi Higuchi – Teikyo University School of Medicine
    Author: Masahiro Shin – Teikyo University School of Medicine
    Author: Yohei Mineharu – Kyoto University Graduate School of Medicine
    Author: Yoshiki Arakawa – Department of Neurosurgery, Kyoto University Graduate School of Medicine
    Author: Naoki Kagawa – Osaka University Graduate School of Medicine
    Author: Shinji Kawabata – Osaka Medical and Pharmaceutical University
    Author: Masahiko Wanibuchi – Department of Neurosurgery, Osaka Medical and Pharmaceutical University
    Author: Takeshi Takayasu – Hiroshima University Hospital
    Author: Fumiyuki Yamasaki – Hiroshima University Hospital
    Author: Kentaro Fujii – Okayama University Graduate School of Medicine
    Author: Joji Ishida – Okayama University Graduate School of Medicine
    Author: Isao Date – Okayama University Graduate School of Medicine
    Author: Keisuke Miyake – Kagawa University
    Author: Hiroshi Fujioka – Kyushu University
    Author: Daisuke Kuga – Department of Neurosurgery, Graduate school of medical sciences, Kyushu University
    Author: Shinji Yamashita – University of Miyazaki Faculty of Medicine
    Author: Hideo Takeshima – University of Miyazaki Faculty of Medicine
    Author: Naoki Shinojima – Kumamoto University
    Author: Akitake Mukasa – Kumamoto University
    Author: Shota Tanaka – The University of Tokyo Hospital
    Author: Akio Asai – Kansai Medical University Hospital
    Author: Ryo Nishikawa – Saitama Medical University International Medical Center
    Author: Masao Matsutani – Saitama Medical University International Medical Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-74 - ON-TRK: a non-interventional study of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion solid tumors
    Location: Exhibit Hall A/B
    Poster Presenter: Ghazaleh Tabatabai – University Hospital Tübingen and Eberhard Karls University Tübingen
    Author: Jonathan Trent – Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
    Author: Silvia Novello – Department of Oncology, San Luigi Hospital, University of Turin
    Author: Francesco Passiglia – Department of Oncology, San Luigi Hospital, University of Turin
    Author: Domnita-Ileana Burcoveanu – Bayer HealthCare Pharmaceuticals, Inc.
    Author: Ricarda Norenberg – Chrestos Concept GmbH & Co. KG
    Author: Theodore Laetsch – Children's Hospital of Philadelphia
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-77 - Post-Progression Treatment after VAL-083 with radiation in newly diagnosed GBM MGMT unmethylated patients
    Location: Exhibit Hall A/B
    Author: Cheng-chen Guo – Sun Yat-sen University Cancer Center
    Author: Qun-ying Yang – Sun Yat-sen University Cancer Center
    Author: Shao-yan Xi – Sun Yat-sen University Cancer Center
    Author: yi-xiang Liao – Sun Yat-sen University Cancer Center
    Author: De-pei Li – Sun Yat-sen University Cancer Center
    Author: Xiao-bing Jiang – Sun Yat-sen University Cancer Center
    Author: Yin-sheng Chen – Sun Yat-sen University Cancer Center
    Author: Chao Ke – Sun Yat-sen University Cancer Center
    Author: Ke Sai – Sun Yat-Sun University Cancer Center
    Author: Richard Schwartz – Kintara Therapeutics
    Poster Presenter: John M. Langlands – Kintara Therapeutics
    Author: Dennis Brown – Kintara Therapeutics
    Author: Zhongping Chen – Sun Yat-sen University Cancer Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-78 - Evaluation of post-progression treatments after VAL-083 in recurrent and newly diagnosed GBM MGMT-unmethylated patients
    Location: Exhibit Hall A/B
    Poster Presenter: Carlos Kamiya-Matsuoka – MD Anderson Cancer Center
    Author: Shiao-Pei Weathers – University of Texas MD Anderson Cancer Center
    Author: W.K. Alfred Yung – University of Texas MD Anderson Cancer Center
    Author: Monica Loghin – University of Texas MD Anderson Cancer Center
    Author: Nazanin K. Majd – University of Texas MD Anderson Cancer Center
    Author: Dennis Brown – Kintara Therapeutics
    Author: John M. Langlands – Kintara Therapeutics
    Author: Richard Schwartz – Kintara Therapeutics
    Author: Stephanie R. Knight – MD Anderson Cancer Center
    Author: Vinay K. Puduvalli – University of Texas MD Anderson Cancer Center
    Author: John F. de Groot – University of California, San Francisco
    Author: Barbara J. O'Brien – University of Texas MD Anderson Cancer Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-79 - Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Anti-Nerve Growth Factor (NGF) Antibody Tanezumab in Subjects with Moderate to Severe Pain Due to Schwannomatosis
    Location: Exhibit Hall A/B
    Poster Presenter: Scott R. Plotkin – Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Author: Jennifer Da – Massachusetts General Hospital
    Author: Danielle Silverman – Massachusetts General Hospital
    Author: Vanessa L. Merker – Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Author: Ina Ly – Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Author: Alona Muzikansky, MA – Massachusetts General Hospital
    Author: Michael W. Parsons – Massachusetts General Hospital/Harvard Medical School
    Author: Pamela L. Wolters – National Cancer Institute
    Author: Lei Xu – Massachusetts General Hospital/Harvard Medical School
    Author: Mark T. Brown – Pfizer
    Author: Scot Styren – Pfizer
    Author: Mehrdad Haghpassand – Pfizer
    Author: Justin T. T. Jordan – Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-81 - Real-world treatment results of relapsed primary central nervous system lymphoma treated by medical therapies
    Location: Exhibit Hall A/B
    Poster Presenter: Motoo Nagane – Department of Neurosurgery, Kyorin University Faculty of Medicine
    Author: Nobuyoshi Sasaki – Department of Neurosurgery, Kyorin University Faculty of Medicine
    Author: Yuki Yamagaishi – Department of Neurosurgery, Kyorin University Faculty of Medicine
    Author: Kuniaki Saito – Department of Neurosurgery, Kyorin University Faculty of Medicine
    Author: Keiichi Kobayashi – Department of Neurosurgery, Kyorin University Faculty of Medicine
    Author: Hirofumi Nakatomi – Department of Neurosurgery, Kyorin University Faculty of Medicine
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-83 - MATRix regimen for newly diagnosed primary CNS diffuse B-cell lymphoma
    Location: Exhibit Hall A/B
    Poster Presenter: Richard M. Green – Kaiser Permanente-Los Angeles Medical Center, Accrual for Kaiser Permanente NCI Community Oncology Research Program
    Author: Ruben Guzman-Marin – Kaiser Permanente-Los Angeles Medical Center
    Author: Candy Miranda – Kaiser Permanente-Los Angeles Medical Center
    Clinical trials: Non-immunologic
  • Friday, Nov 17th
    7:30 PM – 9:30 PM PT
    CTNI-85 - GBM AGILE platform trial for newly diagnosed and recurrent GBM: results of first experimental arm, regorafenib
    Location: Exhibit Hall A/B
    Poster Presenter: Patrick Y. Wen – Dana-Farber Cancer Institute
    Author: Brian Alexander – Foundation Medicine
    Author: Donald Berry – Berry Consultants, LLC
    Author: Meredith Buxton – Global Coalition for Adaptive Research
    Author: Webster Cavenee – UCSD
    Author: Howard Colman – Huntsman Cancer Institute, University of Utah
    Author: John F. de Groot – University of California, San Francisco
    Author: Benjamin M. Ellingson – UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, University of California Los Angeles
    Author: Gary Gordon – Global Coalition for Adaptive Research
    Author: Emma Maria Viktoria Hyddmark – Global Coalition for Adaptive Research
    Author: Mustafa Khasraw – Duke Cancer Institute
    Author: Michael Lim – Stanford University School of Medicine
    Author: Ingo K. Mellinghoff – Memorial Sloan Kettering Cancer Center
    Author: Tom Mikkelsen – Henry Ford Hospital
    Author: James Perry – Sunnybrook Health Sciences Centre, University of Toronto
    Author: Ashley Powell – Global Coalition for Adaptive Research
    Author: Erik P. Sulman – New York University Grossman School of Medicine, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
    Author: Kirk Tanner – National Brain Tumor Society
    Author: Michael Weller – Department of Neurology and Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland
    Author: W.K. Alfred Yung – University of Texas MD Anderson Cancer Center
    Author: Nicolas Blondin – Yale University
    Author: Andrew J. Brenner – UT Health San Antonio Mays Cancer Center
    Author: Omar H. Butt – Washington University
    Author: Macarena I. de la Fuente – Sylvester Comprehensive Cancer Center
    Author: Jan Drappatz – University of Pittsburgh Medical Center
    Author: Fabio M. Iwamoto – Division of Neuro-Oncology, New York-Presbyterian/Columbia University Medical Center
    Author: Lyndon Kim – Mount Sinai Beth Israel
    Author: Eudocia Q. Lee – Dana-Farber Cancer Institute, Boston, MA
    Author: Megan M. Mantica – University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center
    Author: Burt Nabors – Heersink School of Medicine
    Author: Herbert B. Newton – Brain Tumor and Neuro-Oncology Center, University Hospitals of Cleveland Medical Center, Seidman Cancer Center
    Author: David Schiff – University of Virginia School of Medicine
    Author: Tobias Walbert – Henry Ford Health
    Author: Shiao-Pei Weathers – University of Texas MD Anderson Cancer Center
    Author: Timothy F. Cloughesy – University of California Los Angeles
    Author: Andrew B. Lassman – Columbia University Vagelos College of Physicians and Surgeons and New York Presbyterian Hospital
    Clinical trials: Non-immunologic
  • Saturday, Nov 18th
    11:05 AM – 11:15 AM PT
    CTNI-09 - Dose Escalation for Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases: Phase I Results
    Location: Room 109-110
    Author: Erin S. Murphy – Cleveland Clinic
    Author: Kailin Yang – Cleveland Clinic
    Author: John H. Suh – Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic
    Oral Abstract Presenter: Jennifer Yu – Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic
    Author: Glen H. Stevens – Cleveland Clinic
    Author: Lilyana Angelov – Cleveland Clinic
    Author: Michael A. A. Vogelbaum – Department of NeuroOncology, Moffitt Cancer Center
    Author: Gene H. Barnett – Cleveland Clinic
    Author: Manmeet S. Ahluwalia – Miami Cancer Institute, Baptist Health South Florida
    Author: Gennady Neyman – Cleveland Clinic
    Author: Alireza M. Mohammadi – Cleveland Clinic Lerner College of Medicine at CWRU
    Author: Samuel T. Chao – Cleveland Clinic, Ohio
    Clinical trials: Non-immunologic
  • Saturday, Nov 18th
    12:00 PM – 12:05 PM PT
    CTNI-04 - Phase I study of radiation therapy (RT) followed by intrathecal (IT) trastuzumab/pertuzumab in the management of HER2+ breast leptomeningeal disease (LMD)
    Location: Room 109-110
    Oral Abstract Presenter: Kamran A. Ahmed – H. Lee Moffitt Cancer Center & Research Institute
    Author: Priya U. Kumthekar – Northwestern University
    Author: Yolanda Pina – Moffitt Cancer Center
    Author: Youngchul Kim, FLORIDA – Moffitt Cancer Center
    Author: Michelle DeJesus – Moffitt Cancer Center
    Author: Brittany Evernden, FLORIDA – Moffitt Cancer Center
    Author: Daniel E. Oliver – H. Lee Moffitt Cancer Center & Research Institute
    Author: Michael A. A. Vogelbaum – Department of NeuroOncology, Moffitt Cancer Center
    Author: Nam D. Tran – Moffitt Cancer Center
    Author: James K. Liu – Department of Neurooncology/H. Lee Moffitt Cancer Center & Research Institute
    Author: Arnold B. Etame – Moffitt Cancer Center
    Author: Avan Armaghani – Moffitt Cancer Center
    Author: Ricardo Costa – Moffitt Cancer Center
    Author: Aixa Soyano – Moffitt Cancer Center
    Author: Kimberley Lee – Moffitt Cancer Center
    Author: John Arrington – Moffitt Cancer Center
    Author: Marilin Rosa – Moffitt Cancer Center
    Author: Hatem Soliman – Moffitt Cancer Center
    Author: Hsiang-Hsuan Michael Yu – H. Lee Moffitt Cancer Center & Research Institute
    Author: Hyo Han – Moffitt Cancer Center
    Author: Peter Forsyth – Moffitt Cancer Center
    Clinical trials: Non-immunologic
  • Saturday, Nov 18th
    12:05 PM – 12:10 PM PT
    CTNI-03 - Efficacy of WSD0922-Fu in osimertinib-resistant NSCLC with central nervous system (CNS) metastases – Updates from the dose escalation cohort of a first-in-human phase 1 clinical trial (MC1914)
    Location: Room 109-110
    Oral Abstract Presenter: Sani H. Kizilbash – Mayo Clinic (Rochester)
    Author: Kurt A. Jaeckle – Mayo Clinic Florida
    Author: Maciej M. Mrugala – Mayo Clinic Arizona
    Author: Jacob B. Allred – Mayo Clinic
    Author: Stephanie L. Safgren – Mayo Clinic
    Author: Renee McGovern – Mayo Clinic
    Author: Adam Remick – Mayo Clinic
    Author: Joel M. Reid – Mayo Clinic
    Author: Anita A. Lammers – Mayo Clinic
    Author: Wei Zhong – Wayshine Biopharm
    Author: Konstantinos Leventakos – Mayo Clinic
    Author: Aaron S. Mansfield – Mayo Clinic Rochester
    Author: Mohamed Shanshal – Mayo Clinic
    Author: Wen W. Ma – Cleveland Clinic
    Author: Joon H. Uhm – Mayo Clinic
    Author: Jian L. Campian – Mayo Clinic
    Author: Michael W. Ruff – Mayo Clinic
    Author: Ugur T. Sener – Mayo Clinic
    Author: Evanthia Galanis – Mayo Clinic
    Author: Terry C. Burns – Mayo Clinic Rochester
    Author: Ian F. Parney – Mayo Clinic
    Author: Aditya Raghunathan – Mayo Clinic
    Author: Rachael A. Vaubel – Mayo Clinic
    Author: Mark E. Jentoft – Mayo Clinic Florida
    Author: Anja C. Roden – Mayo Clinic
    Author: Caterina Giannini – Mayo Clinic
    Author: Jann N. Sarkaria – Mayo Clinic
    Author: Alex A. Adjei – Cleveland Clinic
    Clinical trials: Non-immunologic
  • Saturday, Nov 18th
    2:53 PM – 3:01 PM PT
    CTNI-51 - A randomized double-blind Phase 3 study of vorasidenib vs placebo in patients with mutant IDH1/2 diffuse glioma (INDIGO): exploratory analysis of variant allele frequency and progression-free survival
    Location: Exhibit Hall C
    Plenary Abstract Presenter: Timothy F. Cloughesy – University of California Los Angeles
    Author: Ingo K. Mellinghoff – Memorial Sloan Kettering Cancer Center
    Author: Martin J. van den Bent – Erasmus MC Cancer Institute
    Author: Deborah T. Blumenthal – Tel Aviv Medical Center, Tel Aviv University
    Author: Mehdi Touat – Pitié Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Sorbonne Université
    Author: Katherine B. Peters – Duke University Medical Center
    Author: Jennifer L. Clarke – University of California San Francisco
    Author: Joe Mendez – Huntsman Cancer Institute at the University of Utah
    Author: Shlomit Yust-Katz – Davidoff Cancer Center at Rabin Medical Center
    Author: Warren P. Mason – Princess Margaret Cancer Centre
    Author: Francois Ducray – Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon
    Author: Yoshie Umemura – Ivy Brain Tumor Center at Barrow Neurological Institute
    Author: L. Burt Nabors – University of Alabama at Birmingham
    Author: Matthias Holdhoff – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Author: Andreas F. Hottinger – University Hospital of Lausanne
    Author: Yoshiki Arakawa – Department of Neurosurgery, Kyoto University Graduate School of Medicine
    Author: Juan M. Sepúlveda – Hospital Universitario 12 de Octubre
    Author: Wolfgang Wick – Universitatsklinikum Heidelberg
    Author: Riccardo Soffietti – University of Turin
    Author: James Perry – Sunnybrook Health Sciences Centre, University of Toronto
    Author: Pierre Giglio – The Ohio State University Wexner Medical Center
    Author: Macarena I. de la Fuente – Sylvester Comprehensive Cancer Center
    Author: Elizabeth A. Maher – University of Texas Southwestern Medical Center
    Author: Sung Choe – Servier Pharmaceuticals
    Author: Dan Zhao – Servier Pharmaceuticals
    Author: Shuchi S. Pandya – Servier Pharmaceuticals
    Author: Lori Steelman – Servier Pharmaceuticals
    Author: Islam Hassan – Servier Pharmaceuticals
    Author: Adriana E. Tron – Servier Pharmaceuticals
    Author: Patrick Y. Wen – Dana-Farber Cancer Institute
    Clinical trials: Non-immunologic
  • Saturday, Nov 18th
    3:45 PM – 3:55 PM PT
    CTNI-73 - Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas
    Location: Room 121-122
    Oral Abstract Presenter: Priscilla K. Brastianos – Massachusetts General Hospital/Harvard Medical School
    Author: Erin Twohy – Mayo Clinic
    Author: Susan Geyer – Mayo Clinic
    Author: Elizabeth R. Gerstner – Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Author: Timothy J. Kaufmann – Mayo Clinic
    Author: Shervin Tabrizi – Massachusetts General Hospital/Harvard Medical School
    Author: Brian Kabat – Mayo Clinic
    Author: Julia Thierauf – Massachusetts General Hospital
    Author: Michael W. Ruff – Mayo Clinic
    Author: Daniela A. Bota, MD, PhD – University of California Irvine
    Author: David A. Reardon – Center for Neuro-Oncology, Dana-Farber Cancer Institute
    Author: Adam L. Cohen – Inova
    Author: Macarena I. de la Fuente – Sylvester Comprehensive Cancer Center
    Author: Glenn J. Lesser – Wake Forest University School of Medicine
    Author: Jian L. Campian – Mayo Clinic
    Author: PK Agarwalla – Rutgers
    Author: Priya U. Kumthekar – Northwestern University
    Author: Bhupinder Mann – NIH
    Author: Shivangi Vora – Ohio State College of Medicine
    Author: Michael Knopp – University of Cincinnati
    Author: A. John Iafrate – Massachusetts General Hospital/Harvard Medical School
    Author: William T. Curry, Jr. – Massachusetts General Hospital/Harvard Medical School
    Author: Daniel P. Cahill – Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School
    Author: Helen A. Shih – Massachusetts General Hospital/Harvard Medical School
    Author: Paul D. Brown – Mayo Clinic
    Author: Sandro Santagata – Brigham and Women's Hospital
    Author: Frederick Barker, 2nd – Massachusetts General Hospital/Harvard Medical School
    Author: Evanthia Galanis – Mayo Clinic
    Clinical trials: Non-immunologic
  • Saturday, Nov 18th
    3:55 PM – 4:05 PM PT
    CTNI-80 - INTUITT-NF2, an adaptive platform-basket trial for NF2-related schwannomatosis patients with progressive schwannomas, meningiomas, and ependymomas: primary outcome of the brigatinib treatment arm
    Location: Room 121-122
    Author: Scott R. Plotkin – Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Author: Dusica Babovic-Vuksanovic – Mayo Clinic
    Author: Christine Dinh – University of Miami
    Author: Geoffrey Fell – Dana-Farber Cancer Institute
    Author: Vanessa L. Merker – Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School
    Oral Abstract Presenter: Phioanh L. Nghiemphu – University of California Los Angeles
    Author: Lorenzo Trippa – Dana Farber Cancer Institute
    Author: Kaley Yohay – NYU Grossman School of Medicine
    Author: Jaishri O. Blakeley – Johns Hopkins
    Clinical trials: Non-immunologic
  • Saturday, Nov 18th
    4:25 PM – 4:35 PM PT
    CTNI-71 - Belzutifan for von Hippel-Lindau disease-related central nervous system (CNS) hemangioblastomas: subgroup of phase 2 LITESPARK-004 study
    Location: Room 121-122
    Oral Abstract Presenter: Othon Iliopoulos – Massachusetts General Hospital Cancer Center and Harvard Medical School
    Author: Ane B. Iversen – Aarhus University Hospital
    Author: Vivek Narayan – University of Pennsylvania
    Author: Benjamin L. Maughan – University of Utah
    Author: Kathryn E. Beckermann – Vanderbilt University Medical Center
    Author: Stephane Oudard – Hôpital Européen Georges Pompidou
    Author: Tobias Else – University of Michigan
    Author: Jodi K. Maranchie – University of Pittsburgh
    Author: Wei Fu – Merck & Co., Inc.
    Author: Rodolfo F. Perini – Merck & Co., Inc.
    Author: Yanfang Liu – Merck & Co., Inc.
    Author: W. Marston Linehan – Center for Cancer Research, National Cancer Institute
    Author: Srinivasan Srinivasan – Center for Cancer Research, National Cancer Institute
    Author: Eric Jonasch – The University of Texas MD Anderson Cancer Center
    Clinical trials: Non-immunologic
  • Sunday, Nov 19th
    10:15 AM – 10:25 AM PT
    CTNI-84 - PNOC022: A Combination Therapy Trial using an Adaptive Platform Design for patients with  Diffuse Midline Gliomas (DMGs) at Initial Diagnosis, Post-Radiation Therapy and at Time of Progression
    Location: Room 121-122
    Author: Cassie Kline – Children's Hospital of Philadelphia
    Author: Andrea T. Franson – University of Michigan
    Author: Anu Banerjee – UCSF
    Author: Alyssa T. Reddy – University of California, San Francisco
    Author: Shannon Raber – UCSF
    Author: Carly Hoffman – UCSF
    Author: Jane Minturn – Children’s Hospital of Philadelphia
    Author: Jasper van der Lugt – Princess Máxima Center for Pediatric Oncology
    Author: E. de Vos-Kerkhof – Princess Máxima Center for Pediatric Oncology
    Author: Dannis van Vuurden – Princess Maxima Center for Pediatric Oncology
    Author: Nicolas Gerber – University Children's Hospital
    Author: Ana Guerreiro Stuecklin – Kispi
    Author: Lindsay B. Kilburn – Children’s National Hospital
    Author: Jennifer Elster – University of California, San Diego
    Author: Nicholas Whipple – University of Utah
    Author: Kenneth J. Cohen – John Hopkins University
    Author: Michal Yalon Oren – Sheba Medical Center
    Author: Sharon L. Gardner – NYU
    Author: Andrew Cluster – St. Louis Children's Hospital
    Author: Susan N. Chi – Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA
    Author: Daniel B. Landi – Duke University
    Author: Geoffrey McCowage – Sydney Children’s Hospitals Network
    Author: Adam Resnick – Children's Hospital of Philadelphia
    Author: Joanna J. Phillips – University of California, San Francisco
    Author: Aashim Bhatia – Children's Hospital of Philadelphia
    Author: Arastoo Vossough – Children's Hospital of Philadelphia
    Author: Elizabeth George – University of California, San Francisco
    Author: Ali Nabavizadeh – University of Pennsylvania
    Author: Steve E. Braunstein – University of California San Francisco
    Author: Nalin Gupta – University of California, San Francisco
    Author: Michael Prados – University of California, San Francisco
    Author: Sebastian M. Waszak – École Polytechnique Fédérale de Lausanne (EPFL)
    Author: Janel Boyle-Lang – University of California, San Francisco (UCSF)
    Author: Annette M. Molinaro – University of California, San Francisco
    Author: Matthew D. Dun – University of Newcastle
    Author: Carl J. Koschmann – University of Michigan
    Author: Javad Nazarian – University Children’s Hospital Zurich
    Oral Abstract Presenter: Sabine Mueller – University of California, San Francisco
    Clinical trials: Non-immunologic
  • Sunday, Nov 19th
    11:35 AM – 11:40 AM PT
    CTNI-69 - Real-time drug screening and genomic testing to determine individualized treatment plans in children and young adults with relapsed medulloblastoma: preliminary report of PNOC027
    Location: Room 121-122
    Oral Abstract Presenter: Margaret Shatara – Washington University in St. Louis, School of Medicine
    Author: Megan R. Paul – University of California San Diego and Rady Children's Hospital
    Author: Janel Boyle-Lang – University of California, San Francisco (UCSF)
    Author: Ashley Meyer – Washington University in St. Louis
    Author: Shannon Raber – UCSF
    Author: Lanipua Yeh-Nayre – Rady Children's Hospital of San Diego
    Author: Aimee Jalkanen – Exact Sciences Corporation
    Author: Lindsay B. Kilburn – Children’s National Hospital
    Author: Roger Packer – Children's National Hospital
    Author: Jennifer Elster – University of California, San Diego
    Author: Alyssa T. Reddy – University of California, San Francisco
    Author: Carl J. Koschmann – University of Michigan
    Author: Adam Kraya – Children's Hospital of Philadelphia
    Author: Adam Resnick – Children's Hospital of Philadelphia
    Author: Michael Prados – University of California, San Francisco
    Author: Cassie Kline – Children's Hospital of Philadelphia
    Author: Sabine Mueller – University of California, San Francisco
    Author: Robert J. J. Wechsler-Reya – Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
    Author: Joshua B. B. Rubin – Washington University School of Medicine
    Clinical trials: Non-immunologic